Prevention of Ischemia-Reperfusion Injury in the Rat Liver by Atrial Natriuretic Peptide by Gerwig, Tobias
 
 
Dissertation zur Erlangung des Doktorgrades 
der Fakultät für Chemie und Pharmazie der 
Ludwig-Maximilians-Universität München 
 
 
 
 
 
 
 
Prevention of Ischemia-Reperfusion Injury in the Rat Liver 
by Atrial Natriuretic Peptide: 
Insights into Mechanisms and Mode of Cell Death 
 
 
 
 
 
 
 
von 
Tobias Gerwig 
aus 
Ludwigsburg 
 
 
 
2002 
 
Erklärung 
 
 
 
Diese Dissertation wurde im Sinne von § 13 Abs. 3 bzw. 4 der Promotionsordnung vom 
29. Januar 1998 von Prof. Dr. A. M. Vollmar betreut. 
 
 
 
Ehrenwörtliche Versicherung 
 
 
Diese Dissertation wurde selbständig, ohne unerlaubte Hilfe erarbeitet. 
 
 
München, am 17.06.2002 
 
 
     Tobias Gerwig 
 
 
 
 
Dissertation eingereicht am     19.06.2002 
1. Gutachter        Prof. Dr. A. M. Vollmar 
2. Gutachter        Prof. Dr. A. Pfeifer 
Mündliche Prüfung am      17.07.2002 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To my family 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“The trouble with experience is  
that by the time you have it  
you are too old to take advantage of it” 
Jimmy Connors 
Contents 
Contents 
A. Introduction ........................................................................... 1 
1. Background and overview ................................................................. 1 
2. Ischemia-reperfusion injury of the liver............................................ 3 
2.1 Significance ...................................................................................................... 3 
2.2 Pathomechanisms in cold ischemia and reperfusion ........................................ 4 
2.2.1 Ischemia .................................................................................................... 4 
2.2.2 Reperfusion ............................................................................................... 4 
3. Mode of cell death............................................................................... 6 
3.1 Necrosis............................................................................................................ 6 
3.2 Apoptosis.......................................................................................................... 7 
3.2.1 Mechanisms .............................................................................................. 8 
4. Therapeutic strategies...................................................................... 11 
4.1 Established therapies ..................................................................................... 11 
4.1.1 Storage and rinse solutions ..................................................................... 11 
4.1.2 Prostaglandins......................................................................................... 11 
4.2 New therapeutic advances ............................................................................. 12 
4.2.1 Ischemic preconditioning ......................................................................... 12 
4.2.2 Antioxidative strategies............................................................................ 12 
4.2.3 Hormonal preconditioning with the atrial natriuretic peptide .................... 12 
5. The Atrial Natriuretic Peptide........................................................... 14 
5.1 Natriuretic peptides......................................................................................... 14 
5.2 Receptors and signal transduction.................................................................. 15 
5.3 cGMP-dependent signaling ............................................................................ 16 
5.4 Cyclic nucleotide dependent protein kinases.................................................. 17 
5.4.1 cGMP-dependent protein kinases ........................................................... 18 
5.4.2 cAMP-dependent protein kinases............................................................ 19 
6. The heme oxygenase system .......................................................... 20 
6.1 Biological functions ......................................................................................... 20 
6.2 Heme oxygenase-1 in oxidant stress.............................................................. 21 
6.3 Heme oxygenase-1: significance in IRI........................................................... 21 
7. The isolated perfused rat liver: general aspects............................ 22 
B. Materials and Methods........................................................ 23 
1. The isolated perfused rat liver ......................................................... 23 
 
Contents 
1.1 Animals ...........................................................................................................23 
1.2 Solutions .........................................................................................................23 
1.3 Model of the isolated perfused rat liver ...........................................................23 
1.4 Experimental setting........................................................................................25 
1.4.1 Continous liver perfusion..........................................................................25 
1.4.2 Model of cold ischemia and reperfusion...................................................25 
1.4.3 Treatment protocols .................................................................................25 
1.5 Parameters of liver function.............................................................................26 
1.5.1 Lactate dehydrogenase efflux ..................................................................26 
1.5.2 Bile efflux .................................................................................................26 
1.5.3 Portal pressure.........................................................................................27 
2. Liver cell culture................................................................................ 27 
2.1 Animals ...........................................................................................................27 
2.2 Solutions .........................................................................................................27 
2.3 Cultivation .......................................................................................................28 
2.4 Isolation of primary hepatocytes......................................................................29 
2.5 Isolation of Kupffer cells ..................................................................................30 
3. Isolation of ribonucleic acids........................................................... 31 
3.1 Extraction of ribonucleic acids.........................................................................31 
3.1.1 Solutions ..................................................................................................31 
3.1.2 Guanidine thiocyanate/cesiumchloride-method .......................................31 
3.2 Measurement of nucleic acid concentration ....................................................32 
3.3 Gel electrophoretic separation of nucleic acids ...............................................32 
3.3.1 Solutions ..................................................................................................33 
3.3.2 Agarose gel electrophoresis.....................................................................33 
3.3.3 Staining ....................................................................................................33 
3.4 Separation of mRNA from totRNA...................................................................34 
4. Northern blot...................................................................................... 34 
4.1 Bacteria ...........................................................................................................34 
4.1.1 Strain........................................................................................................34 
4.1.2 Growth media and antibiotics...................................................................35 
4.1.3 Cultivation ................................................................................................35 
4.2 Vectors............................................................................................................35 
4.2.1 Employed plasmids..................................................................................35 
4.3 Amplification of a cDNA-Northern blot probe...................................................36 
4.3.1 Preparation of competent cells.................................................................36 
4.3.2 Transformation of competent E. coli ........................................................36 
Contents 
4.3.3 Mini-prep DNA isolation........................................................................... 37 
4.3.4 Agarose gel electrophoresis .................................................................... 37 
4.3.5 Midi-prep DNA isolation with Qiagen Plasmid Midi Kit............................. 38 
4.3.6 Restriction endonuclease digestion ......................................................... 39 
4.3.7 Extraction of DNA from agarose gels ...................................................... 39 
4.3.8 Sequencing of double stranded DNA ...................................................... 40 
4.4 DNA labeling with radioactive nucleotides ...................................................... 40 
4.4.1 Synthesis of radioactively labeled HO-1 cDNA........................................ 40 
4.4.2 Synthesis of radioactively labeled 28S RNA oligonucleotides ................. 41 
4.4.3 Removal of unincorporated dNTPs.......................................................... 41 
4.5 Northern blot ................................................................................................... 42 
4.5.1 Solutions.................................................................................................. 42 
4.5.2 Transfer of electrophoretically separated RNA onto a nylon membrane . 42 
4.5.3 Hybridization............................................................................................ 43 
4.5.4 Detection ................................................................................................. 43 
5. In situ hybridization .......................................................................... 43 
5.1 Hybridization................................................................................................... 43 
5.2 Detection ........................................................................................................ 44 
6. Reverse transcriptase polymerase chain reaction ........................ 44 
6.1 Reverse transcription...................................................................................... 44 
6.2 Primers and reaction conditions...................................................................... 45 
6.3 Polymerase chain reaction ............................................................................. 45 
6.4 Electrophoresis of amplification products ....................................................... 46 
7. Detection of proteins by Western blotting...................................... 46 
7.1 Preparation of samples................................................................................... 46 
7.1.1 Solutions.................................................................................................. 46 
7.1.2 Preparation of cellular protein extracts from rat liver tissue ..................... 47 
7.1.3 Preparation of cellular protein extracts from rat hepatocytes................... 47 
7.1.4 Preparation of samples for protein electrophoresis ................................. 47 
7.2 Measurement of protein concentration: Lowry-assay ..................................... 47 
7.3 SDS-polyacrylamide gel electrophoresis (SDS-Page) .................................... 48 
7.3.1 Solutions.................................................................................................. 48 
7.3.2 Electrophoresis........................................................................................ 49 
7.4 Coomassie blue staining................................................................................. 49 
7.4.1 Solutions.................................................................................................. 49 
7.4.2 Staining procedure .................................................................................. 50 
7.5 Immunologic detection by Western blotting .................................................... 50 
 
Contents 
7.5.1 Solutions ..................................................................................................50 
7.5.2 Protein transfer by semidry blotting..........................................................51 
7.5.3 Used antibodies .......................................................................................51 
7.5.4 Incubation with antibodies and chemiluminescence detection .................52 
8. In vitro phosphorylation by protein kinase A ................................. 52 
8.1 Solutions .........................................................................................................52 
8.2 Preparation of samples ...................................................................................53 
8.2.1 Liver tissue...............................................................................................53 
8.2.2 Primary hepatocytes ................................................................................53 
8.3 Protein kinase A assay....................................................................................53 
9. Fluorimetric enzyme activity assay ................................................. 54 
9.1 Solutions .........................................................................................................55 
9.2 Caspase-3-like acitivity assay .........................................................................55 
9.3 Protein determination: Pierce-assay (BCA-assay) ..........................................55 
10. Histological analysis...................................................................... 56 
10.1 TUNEL staining ...............................................................................................56 
10.2 Immunohistochemistry ....................................................................................56 
10.3 Hematoxylin/eosin (H/E) staining ....................................................................57 
10.4 Trypan blue uptake of liver tissue....................................................................57 
11. Statistics ......................................................................................... 58 
C. Results..................................................................................59 
1. Determination of apoptotic and necrotic cell death....................... 59 
1.1 Evaluation of apoptosis ...................................................................................59 
1.1.1 ANP and 8-Br-cGMP preconditioning reduce caspase-3-like activity and 
caspase-3 processing ............................................................................................59 
1.1.2 ANP and 8-Br-cGMP preconditioning decrease the proportion of TUNEL-
positive cells ...........................................................................................................63 
1.2 Evaluation of necrosis .....................................................................................64 
1.2.1 Decreased degenerative changes in ANP pre-treated livers....................64 
1.2.2 Trypan blue uptake is significantly reduced by ANP preconditioning .......65 
2. Signal transduction of ANP protection ........................................... 66 
2.1 Involvement of cGMP-dependent protein kinases...........................................66 
2.2 Effect of cGMP- and cAMP-dependent protein kinase inhibitors on the 
antiapoptotic property of ANP ....................................................................................68 
2.2.1 Effects on caspase-3-like activity .............................................................68 
2.3 Activation of cAMP-dependent protein kinase by ANP....................................69 
Contents 
2.3.1 Liver......................................................................................................... 69 
2.3.2 Hepatocytes............................................................................................. 70 
3. Heme oxygenase-1............................................................................ 71 
3.1 cGMP-independent induction of HO-1 by ANP preconditioning...................... 71 
3.2 Localization of HO-1 ....................................................................................... 74 
3.3 Induction of HO-1 in isolated Kupffer cells...................................................... 75 
3.4 ZnPP perfusion ............................................................................................... 76 
D. Discussion ........................................................................... 78 
1. Reduction of apoptosis and necrosis by ANP ............................... 78 
1.1 Reduction of apoptosis by ANP treatment ...................................................... 78 
1.2 Caspase-3 upregulation during cold ischemia ................................................ 79 
1.3 ANP reduces early degenerative cell changes ............................................... 79 
1.4 Reduction of necrosis by ANP treatment ........................................................ 80 
2. Signal transduction of ANP protection ........................................... 80 
2.1 cGMP-dependent protein kinases................................................................... 80 
2.2 cAMP-dependent protein kinases ................................................................... 81 
2.3 Further potentially involved pathways............................................................. 82 
3. Heme Oxygenase-1 expression ....................................................... 83 
3.1 HO-1 expression during ischemia and reperfusion ......................................... 83 
3.2 ANP induces HO-1 in rat livers ....................................................................... 83 
3.3 Induction of HO-1 in Kupffer cells ................................................................... 84 
3.4 Induction of HO-1 by ANP is independent of cGMP ....................................... 84 
3.5 Perfusion with ZnPP ....................................................................................... 85 
E. Summary .............................................................................. 86 
F. Appendix .............................................................................. 87 
1. Abbreviations .................................................................................... 87 
2. Alphabetical order of companies .................................................... 90 
3. Publications....................................................................................... 92 
3.1 Abstracts......................................................................................................... 92 
3.2 Original publications ....................................................................................... 93 
G. References ........................................................................... 94 
H. Acknowlegements............................................................. 112 
I. Curriculum vitae................................................................... 113
 
Introduction  1 
A. Introduction 
1. Background and overview 
The temporary disconnection of blood flow is a necessity in a number of surgical 
procedures on the liver. This event, also referred to as ischemic period, can last for a 
short time as in liver resection at maintained organ temperature or can last up to several 
hours in the cold as it is the case in liver transplantation. Both insults cause detrimental 
cellular mechanisms that are even augmented by the subsequent restoration of blood flow 
after surgery or insertion of an organ, culminating in the manifestation of ischemia 
reperfusion injury (IRI). 
In the field of hepatic transplantation, the preservation injury, a severe form of IRI, 
contributes to serious complications. Primary non-function, dysfunction, and non-
anastomotic biliary strictures frequently question the outcome of liver transplantation and 
are major causes of retransplantation and mortality. Because of the increasing numbers of 
orthotopic liver transplantations and the concomitant lack of suitable donor organs, there 
is a great demand for better protection against IRI to decrease the rate of preservation–
related complications. Additionally, successful liver transplantation reduces the need of 
retransplantation and therefore increases the number of urgently required organs 
available for liver transplantation. 
Several approaches have been made in the recent time in order to protect from hepatic 
IRI. Among them, preconditioning with the Atrial Natriuretic Peptide (ANP) (Gerbes et al., 
1998) emerged as a potential candidate making livers more resistant against IRI. It was 
demonstrated in the model of the isolated perfused rat liver, that ANP is able to reduce 
cell damage and improve liver function. Cytoprotection is thereby mediated via the 
guanylyl cyclase-coupled A receptor. First mechanistical investigations revealed that 
activation of transcription factors and expression of cytokines, known to participate in cell 
damage, are mitigated, and cytoprotective pathways are enabled. 
 
 
 
 
2 Background and overview 
Aim of the present work was the detailed characterization of cell death and ANP 
protection in IRI of the isolated perfused rat liver. The following questions should be 
answered: 
1. Is apoptotic cell death involved in IRI of the isolated perfused rat liver? Which 
liver cell types are affected and does ANP influence this kind of cell death? 
2. Elucidation of signal transduction processes: which cGMP-dependent proteins 
are involved in ANP mediated protection? 
3. Does ANP induce the expression of the heme oxygenase-1 (HO-1), a 
cytoprotective heat shock protein? Which liver cell types are affected and is there 
a causal link between HO-1 induction and ANP cytoprotection? 
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2. Ischemia-reperfusion injury of the liver 
2.1 Significance 
Since Thomas Starzl in 1963 performed the first human liver transplantation (Starzl, 
1978), this technique has evolved to an established therapy for end stage liver disease or 
acute liver non-function. Due to the increasing experience and optimization of surgical 
technique and immunosuppression, survival rates were improved significantly and are 
today about 85%-90% after one year (Keeffe, 2001). Superior organ preservation also 
accounts for this development. The commonly used University of Wisconsin (UW) solution 
(Southard et al., 1995) facilitates preservation times for up to 20 h and therefore replaced 
the former, less effective Euro-Collins solution (Crenesse et al., 1994). 
Despite improved preservation techniques, the success of liver transplantations is still 
influenced by IRI (Bilzer et al., 2000). Long preservation times are in direct proportion to 
the incidence of retransplantation, indicating that preservation injury is a major cause for 
graft loss. In 5 to 15% of transplanted livers a primary non-function occurs that can be 
defined by transaminase increase, loss of bile production and disturbances in clotting. 
This event highly correlates with preservation time and strongly increases after more than 
12 h of preservation (Furukawa et al., 1991). In this case, retransplantation is inescapable. 
30% of graft recipients suffer from primary dysfunction, another grave complication. It is 
characterized by a post-surgical increase of liver enzymes, accompanied by a retarded 
regeneration of hepatic synthesis (Lemasters et al., 1995) resulting in a three times higher 
risk of graft loss. 
Non-anastomotic biliary strictures also show a correlation with the preservation time 
(Sanchez-Urdazpal et al., 1993). These ischemic bile duct strictures emerge during the 
first three months after transplantation and are difficult to cure. In hard cases, 
retransplantation is the only way for therapy. 
In summary, improved protection against IRI could decrease the rate of preservation 
related complications and, moreover, should increase the number of organs available for 
liver transplantation. Elucidation of the involved pathomechanisms and developing 
protective strategies are therefore important objectives. 
 
4 Ischemia-reperfusion injury of the liver 
2.2 Pathomechanisms in cold ischemia and reperfusion 
In recent years, the knowledge of mechanisms underlying IRI markedly improved. There 
is general agreement that IRI is caused by a combination of cellular changes in the 
ischemic period and the consecutive reperfusion period, where blood flow and oxygen 
supply are restored.  
2.2.1 Ischemia 
The main feature of the ischemic phase is the loss of mitochondrial respiration. Reduced 
energy status leads to a breakdown of energy-dependent metabolic pathways and 
transport processes, finally resulting in perturbation of ion homeostasis and activation of 
proteases (Clavien et al., 1992; Rosser et al., 1995). These include aspartate proteases, 
matrix metalloproteases, and Ca2+-requiring calpains (Takei et al., 1991; Upadhya et al., 
1997; Calmus et al., 1995), which proteolytically cleave and disrupt membrane and 
cytoskeletal proteins. Additionally, endonucleases cause nuclear chromatin damage, and 
Ca2+-dependent phospholipases alter membrane fluidity and function (Trump et al., 1992). 
The activation of ATPases by increased cytosolic calcium hastens ATP depletion, even 
worsening the low cellular energy state during ischemia (Rosser et al., 1995). In organ 
transplantation, hypothermic storage itself leads to negative effects like cell swelling and 
calcium alterations despite the beneficial properties of low temperatures to prolong the 
possible storage time by reducing the metabolic rate (Hansen et al., 1994; Marsh et al., 
1989). Sinusoidal endothelial cells (SEC) seem to be more susceptible to cold ischemia 
than hepatocytes (Otto et al., 1984) and contribute to reduced organ viability by detaching 
from their cellular matrix at the beginning of the reperfusion process (McKeown et al., 
1988). 
2.2.2 Reperfusion 
When blood supply is restored in the reperfusion period, a complex network of hepatic 
and extrahepatic mechanisms leads to an aggravation of liver damage. Kupffer cells, the 
liver macrophages, are rapidly activated and are commonly seen as central mediators of 
hepatic pathomechanisms (Bilzer et al., 2000; Mochida et al., 1994). By releasing reactive 
oxygen species (ROS), a variety of related signal transduction processes gets started 
(Wanner et al., 1996). The proposed direct toxicity of ROS in lipid peroxidation appears 
unlikely to be the main mechanism of injury. In contrast, secretion of platelet activating 
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factor (PAF) (Zhou et al., 1992), interleukins, and TNF-α (Le Moine et al., 1997) by 
endothelial cells and monocytes, and activation of the redox sensitive transcription factors 
(TF) AP-1 and NF-κB (Kiemer et al., 2000b) initiate an inflammatory response with 
upregulation of adhesion molecules (Jaeschke et al., 1996), neutrophil sequestration and 
priming of neutrophils and macrophages for increased toxicity. The development of 
delayed perfusion failure in the hepatic microcirculation further contributes to IRI. This is 
caused by an increased formation of vasoconstrictors, such as endothelin-1 (ET-1) and 
ROS and a reduction of vasodilators such as nitric oxide (NO) leading to an imbalance in 
liver perfusion. 
Hepatocyte Hepatocyte
Ischemia Reperfusion
NG
SEC
KC
Si
nu
so
id
ATP ↓
Ca2+ ↑
Na+ ↑
Proteases ↑
Phospholipases ↑
ROS, PAF
Cytokines, TF
Adhesion molecules
ET-1
Vascular inflammation
Mircocirculatory disturbances  
figure 1: Summary of the pathomechanisms of ischemia reperfusion injury. KC: Kupffer cell, 
NG: neutrophil granulocyte, SEC: sinusendothelial cell, ROS: reactive oxygen species, PAF: 
platelet activating factor, ET-1: endothelin-1, TF: transcription factors. 
 
6 Mode of cell death 
3. Mode of cell death 
When blood flow is re-established after the ischemic period, damaged cells are still able to 
survive if they are reversibly injured. However, depending on the intensity and duration of 
the ischemic insult, variable numbers of cells are already irreversibly injured or may be 
severely damaged in the reperfusion period exceeding the point of no return. In this case, 
cell death can happen in two principal patterns, namely necrosis and apoptosis (reviewed 
in (Majno et al., 1995; Raffray et al., 1997; Leist et al., 2001)). The switch to the respective 
kind of cell death is discussed to depend on the severity of death stimulus: for example, 
moderate hypoxia may induce apoptosis and severe hypoxia may induce necrosis 
(Kaplowitz, 2000). Furthermore, it was proposed that there are various intermediates 
between apoptotic and necrotic cell death (Raffray et al., 1997; Nicotera et al., 1999). 
In the reperfused liver, there is evidence that reactive oxygen species and proteases 
cause hepatocellular necrosis (Mavier et al., 1988; Nieminen et al., 1995; Nieminen et al., 
1997). Apoptotic cell death was reported to account to a large degree to IRI (Gao et al., 
1998; Cursio et al., 1999; Kohli et al., 1999). The significance of this kind of cell death for 
warm (Gujral et al., 2001) or cold (Redaelli et al., 2002) hepatic IRI, however, has been 
questioned. 
3.1 Necrosis 
Necrosis refers to the progressive degradation of cell structure that occurs after death 
caused by severe, injurious changes in environmental conditions (Walker et al., 1988). 
Necrosis describes a passive, barely regulated form of cell demise that affects mainly cell 
groups. The morphological changes are characterized by increased eosinophilia and cell 
swelling. Necrotic cells show discontinuities in plasma and organelle membranes, marked 
dilation of mitochondria and nuclear changes. This non-specific DNA breakdown of DNA 
is called karyolysis, when the basophilia of the chromatin fades by increased DNase 
activity. In contrast pyknosis, as seen in apoptosis, is characterized by nuclear shrinkage 
and increased basophilia. Finally, necrotic cell lysis results in a significant inflammatory 
response by release of cytoplasmatic components attracting phagocyting macrophages 
(Walker et al., 1988; Majno et al., 1995; Raffray et al., 1997). 
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3.2 Apoptosis 
Apoptosis was initially recognized in 1972 by its distinctive morphology and named after 
the greek designation for “falling off” (Kerr et al., 1972), referring to autumn foliage. It is a 
form of cell death designated to eliminate unwanted host cells through activation of a 
coordinated, internally programmed series of events. It occurs for example as a 
physiological process during development, and as a homeostatic mechanism in order to 
remove cells damaged by disease or noxious agents. On the other hand, dysregulation of 
apoptosis can also be involved in exaggerated or suppressed cell demise in a number of 
diseases like cancer, AIDS, and autoimmune or neurodegenerative disorders (Thompson, 
1995). 
Chromatin condensation represents the most characteristic feature of apoptosis. Other 
morphological alterations, often limited to single or only few cells, comprise shrinkage into 
tightly packed and smaller cells. The apoptotic cell first shows extensive surface blebbing, 
then undergoes fragmentation into a number of membrane bound apoptotic bodies 
composed of cytoplasm and tightly packed organelles, with or without a nuclear fragment. 
Finally, apoptotic bodies or cells are phagocyted by parenchymal cells or macrophages 
and are subsequently degraded within lysosomes.  
In contrast to necrosis, plasma membranes are thought to remain intact during apoptosis, 
preventing release of potentially inflammatory content (Walker et al., 1988). However, 
recent findings suggest that apoptotic cell death can be equally as effective as necrosis in 
inducing hepatic inflammation (Faouzi et al., 2001; Jaeschke, 2002). 
 
8 Mode of cell death 
NORMAL
Apoptotic 
body
Phagocyte
NECROSIS APOPTOSIS  
figure 2: The ultrastructural changes seen in coagulation necrosis and apoptosis. In apoptosis, 
the initial changes consist of nuclear chromatin condensation and fragmentation, followed by 
cytoplasmic budding and phagocytosis of the extruded apoptotic bodies. Signs of necrosis 
include chromatin clumping, organellar swelling, and membrane damage (adapted from 
(Walker et al., 1988). 
3.2.1 Mechanisms 
Apoptosis represents a highly coordinated way of cell death. This is reflected by the 
complexity of apoptotic signal transduction. Apoptotic stimuli generate signals that are 
either transmitted across the plasma membrane to intracellular regulatory molecules or 
address directly to targets present within the cell. 
3.2.1.1 Extracellular signaling 
Growth factors, certain hormones or cytokines are required as normal survival stimuli. The 
absence of such factors activates preexisting death programs und thus triggers cell death 
(Boise et al., 1995; Collins et al., 1994).  
Distinct surface receptors were discovered transducing death signals into the cell. Among 
them, the death receptors TNF-R1 and CD95 (Apo-1/Fas) and their ligands TNF and 
CD95L, respectively, are the most prominent for inducing apoptosis in the liver (Faubion 
et al., 1999; Ashkenazi et al., 1998). 
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In the liver, the physiological role of the death receptor-mediated induction of apoptosis 
represents the maintenance of hepatic tissue homeostasis and of liver function. Therefore, 
senescent (Benedetti et al., 1988) or toxin damaged (Leist et al., 1997) hepatocytes are 
rapidly eliminated by apoptosis. Pathologically increased or diminished apoptosis rates 
are basis for several hepatic disorders. Excessive apoptosis is found, for example, in viral 
or autoimmune hepatitis, alcoholic hepatitis, Wilson’s disease, primary biliary cirrhosis, 
transplant rejection, and toxic liver injury, whereas pathologically decreased apoptosis 
rates account for hepatic carcinogenesis (Patel et al., 1999). 
After receptor ligand interaction, the death signal is further transmitted via death domain 
containing adapter proteins to activation of caspase-8, a member of the caspase-family of 
proteases. In the case of TNF, signaling is extremely complex leading to both cell death 
and cell survival signals. (Faubion et al., 1999). 
3.2.1.2 Intracellular signaling 
Intracellular signaling may also cause apoptosis. If irreversible DNA damage occurs, the 
tumor suppressor protein p53 accumulates and induces apoptosis if repair is impossible 
(Lane, 1992; Kastan et al., 1991).  
The mitochondrial pathway is used extensively in response to extracellular triggers, such 
as physicochemical agents (heat, radiation, xenobiotics, free radicals, hypoxia and viral 
infections) (Green et al., 1998). The results are mitochondrial permeability transitions and 
formation of pores with subsequent reduction of mitochondrial membrane potential and 
mitochondrial swelling. Apoptosis is then provoked by the release of AIF and Smac/Diablo 
and of cytochrome-c into the cytoplasm, which in turn forms in combination with Apaf-1 
and caspase-9 the apoptosome complex. These proapoptotic events can be counteracted 
or enforced by proteins of the Bcl-2 family (Reed, 1997). 
3.2.1.3 Execution 
The death signal from extracellular and intracellular origin are transmitted via a group of 
initiator caspases to effector caspases, which are the final executioners of apoptosis 
(Salvesen, 1999; Thornberry et al., 1998). Caspases are a family of cysteine proteases 
that specifically cleave substrates after aspartic acid residues. They are present in all 
mammalian cells as latent inactive proenzymes (zymogens), and can be proteolytically 
processed to their active forms.  
The 14 caspases known to date have been subdivided into three groups. Apoptosis 
related caspases are classified into initiator (Caspase-6,8,9,20) and executioner caspases 
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(Caspase-2,3,7), whereas a third group is implicated in the maturation of the cytokines IL-
1β and IL-18 and does not have a significant role in apoptosis. 
Initiator caspases can cleave executioner caspases, thereby triggering a caspase 
cascade, including a number of caspase-caspase interactions. The executioner caspases 
(i.e. caspase-2,3,7) cleave a variety of death substrates with their subsequent loss of 
function finally resulting in the morphological and biochemical characteristics of an 
apoptotic cell. For example, structural proteins such as lamins or fodrin, are inactivated. 
Limited proteolysis can also result in a gain of biological activity as demonstrated by 
fragmentation of nuclear DNA by activation of a DNase (Hengartner, 2000). 
 
Initiator caspases
Executioner caspases
Endonuclease
activation Catabolism 
of cytosketon
Death receptor
activation
withdrawal of growth
factors/hormones
Injury
Mitochondrion
DNA damage
p53
apoptosome
Nucleus
DNA fragmentation
Cytoplasmic budding
 
figure 3: Schematic representation of principle apoptotic events (for details see text). 
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4. Therapeutic strategies 
At presence, only about two thirds of organs offered for transplantation are accepted and 
marginal organs, such as fatty livers or livers from donors with prolonged intensive care or 
prolonged ischemia time, are rejected (Lemasters et al., 1995). These organs are more 
vulnerable to IRI, and graft as well as patient survival is diminished after use of such 
organs (Lemasters et al., 1995; Trevisani et al., 1996). Therefore, better protection against 
IRI and strategies to counteract the pathomechanisms are of great interest. 
4.1 Established therapies 
4.1.1 Storage and rinse solutions 
Presently, liver preservation is performed in the University of Wisconsin (UW)-solution. 
This preservation solution has superior properties against the older Euro-Collins solution 
and is also applied for conservation of other organs, such as heart, kidney, and lung 
(Southard et al., 1995). Among its complex composition, the ingredients lactobionate and 
glutathione were identified as protective agents during liver preservation. Lactobionate 
has strong osmotic properties and was shown to reduce hypothermic cell swelling 
(Southard et al., 1995), whereas glutathione seems to be beneficial because of its 
antioxidant properties. 
To prevent reperfusion injury, flushing of the graft with Carolina rinse solution containing 
antioxidants before transplantation proved to be superior to Ringer’s lactate and albumin 
solution. Kupffer cell activation and neutrophil adherence were inhibited, and hepatic 
microcirculation and survival were finally improved (Post et al., 1993; Gao et al., 1991). 
4.1.2 Prostaglandins 
Prostaglandin E1 (PGE1) (Greig et al., 1989) has been used clinically, for many years, to 
reduce primary graft non-function. It has been proposed that PGE1 infusion during 
reperfusion of livers may improve hepatic blood flow via microvasodilatory properties 
(Richardson et al., 1981), protection of the sinusoidal endothelial cells, or decreased 
platelet adhesion (Clavien et al., 1992). Numerous studies have been performed in animal 
models, demonstrating beneficial effects in transplant or ischemic injury setting (Olthoff et 
al., 1991). However, the clinical benefits of PGE1 infusion following liver transplantation 
were not of advantage with respect on patient and graft survival and incidence of organ 
dysfunction (Olthoff, 2001). Despite the lack of clinical evidence, many programs continue 
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to use PGE1 in recipients in whom there is a concern for poor graft function. 
4.2 New therapeutic advances 
4.2.1 Ischemic preconditioning 
Ischemic preconditioning refers to a phenomenon in which tissues are rendered resistant 
to the deleterious effects of IRI by previous exposure to brief periods of vascular 
occlusion. The protective effects were first described in the myocardium (Murry et al., 
1986) and have also been demonstrated in the liver. In rats, ischemic preconditioning prior 
to harvesting of the liver for transplantation resulted in improved survival and decreased 
serum transaminases and TNF-α (Yin et al., 1998). The protective effect is thought to 
result, at least in part, from the release of adenosine by the ischemic tissue (Peralta et al., 
1999). Moreover, attenuation of postischemic generation of reactive oxygen species 
(ROS) seems to mediate protection (Peralta et al., 2002). First successful results in 
human liver resection are pointing to a potentially clinically relevant procedure (Clavien et 
al., 2000). 
4.2.2 Antioxidative strategies 
Generation of ROS is a central event in the reperfusion period (Jaeschke, 1996). Kupffer 
cell and neutrophil activation and activation of xanthine oxidase are the major sources of 
these detrimental mediators. Extracellular fluids, such as blood plasma, contain little 
antioxidant capacity as compared to hepatocytes (Halliwell et al., 1990). Therefore, 
administration of antioxidants during the early phase of reperfusion was suggested to 
have beneficial effects. In fact, various antioxidants demonstrated their protective 
potential: glutathione (GSH) (Bilzer et al., 1999b), superoxide dismutase (Mizoe et al., 
1997), allopurinol (Kusumoto et al., 1995), N-acetylcysteine (Koeppel et al., 1996), and α-
tocopherol (Marubayashi et al., 1986) have all been shown to attenuate hepatic IRI. 
4.2.3 Hormonal preconditioning with the atrial natriuretic peptide 
The basis of this thesis is the protection of rat livers against IRI by the atrial natriuretic 
peptide (ANP) which was demonstrated in warm and cold ischemic and reperfused rat 
livers (Bilzer et al., 1994; Gerbes et al., 1998). Pretreatment of livers with ANP revealed 
decreased cell damage as assessed by less release of lactate dehydrogenase. Liver 
function was improved as could be seen by increased bile production. All ANP effects 
were mimicked by 8-Br-cGMP, an analog of ANP’s second messenger cGMP, which 
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indicates guanylyl cyclase-A receptor/cGMP mediated signaling of cytoprotection. 
Mechanistic investigations revealed that ANP could mediate its hepatoprotective actions 
via reduced activation of the redox sensitive transcription factors NF-κB and AP-1 
resulting in decreased expression of the cytokine TNF-α (Kiemer et al., 2000b). In 
addition, an influence of ANP on Kupffer cell (KC) mediated injury could be demonstrated 
by (Bilzer et al., 1999a): ANP was able to protect liver cells against oxidative stress of 
activated Kupffer cells without influencing superoxide formation of KC. 
In addition, ANP has recently been shown to activate the heat shock transcription factor 
(HSF) and the heat shock protein 70 (HSP70) (Kiemer et al., 2002b), both mediators of 
the heat shock response (Jäättelä, 1999). HSP70 is not only discussed to confer 
thermotolerance, but also to protect against ROS toxicity and IRI by renaturation or 
refolding of partially denatured or unfolded proteins (Becker et al., 1994) and to prevent 
apoptotic cell death (Beere, 2001; Ikeyama et al., 2001). Induction of HSP70 in the liver 
was suggested to contribute to attenuation of IRI (Terajima et al., 2000; Kiemer et al., 
2002b). 
Thus, ANP appears to protect liver cells by either directly inhibiting mediators of cell 
damage or to improve resistance of cells to cytotoxic products. Therefore, pretreatment of 
livers with ANP subsequently subjected to ischemia and reperfusion may be a new 
promising therapeutic intervention to protect livers against IRI. 
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5. The Atrial Natriuretic Peptide 
The atrial natriuretic peptide (ANP) was first described by (de Bold et al., 1981), and 
investigated for its actions on volume homeostasis by shutting off volume retentive stimuli 
in the kidney. In addition to its vasodilating properties, this peptide shows effects on other 
biological functions, e.g. of the immune system. In this context, ANP was suggested to 
possess anti-inflammatory potential in particular on macrophage function (Kiemer et al., 
1998; Kiemer et al., 2000a; Kiemer et al., 2002c) and to protect endothelial cells from 
TNF-α induced inflammation (Kiemer et al., 2002d). Concerning cytoprotective action, 
ANP was shown to preserve kidney function after renal ischemia and reperfusion 
(Nakamoto et al., 1987; Shaw et al., 1987). 
5.1 Natriuretic peptides 
The natriuretic peptides (NP) are cyclic molecules that are derived from different precursor 
molecules encoded by separate genes. They all exhibit structural, if not functional, 
homology (Kone, 2001). 
The first member of the natriuretic peptide family was discovered in 1981 when de Bold 
and coworkers injected atrial extracts into rats and detected increased diuresis, 
natriuresis, and hypotension (de Bold et al., 1981). The responsible compound was 
identified as a peptide and the amino acid sequence and the corresponding cDNA were 
subsequently elucidated (de Bold et al., 1983; Flynn et al., 1983). 
After ANP, further members of natriuretic peptides were identified: brain natriuretic peptide 
(BNP), C-type natriuretic peptide (CNP), and the recently identified dendroaspis natriuretic 
peptide (DNP). Other related peptides include guanylin and uroguanylin (reviewed in 
(Levin et al., 1998; Venugopal, 2001)) 
All NPs exhibit a cyclic structure of 17 amino acids that is formed by a disulfide bond 
between two cysteine residues (Currie et al., 1984). This represents the prerequisite for 
the biological activity of the peptides (Misono et al., 1984). Eleven of the cyclic amino 
acids are homologous in each NP, whereas the number of amino acids differ at the C- and 
N-terminal end. The amino acid sequence of ANP consists of 28 amino acids and is 
identical in all mammals except of one variation at position 110 (Rosenzweig et al., 1991). 
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figure 4: Structure and amino acid sequence of ANP. 
The biosynthesis of ANP is characteristical for peptide hormones. The ANP gene is 
transcribed into mRNA that codes for a 152 amino acid peptide, the so called pre-pro-
ANP. By separation of a signal peptide at the N-terminus, pro-ANP is released and 
accumulated in granula (Rosenzweig et al., 1991). Upon stimulation, such as stretching of 
the atria, pro-ANP is cleaved into the amino terminal fragment ANP 1-99 and the 
biologically active hormone ANP 99-126. Secretion of ANP from atrial myocytes into the 
circulation is performed by exocytosis (Nemer et al., 1984). 
5.2 Receptors and signal transduction 
The natriuretic peptides exert their effects through interaction with high-affinity receptors 
on the surface of target cells. Three natriuretic peptide receptors (NPR) have been 
identified (reviewed in (Venugopal, 2001; Levin et al., 1998)):  
NPR-A and NPR-B are linked to the cGMP-dependent signaling cascade and mediate 
most of the effects of natriuretic peptides. The NPR-A receptor binds both ANP and BNP 
with preference for ANP. CNP is the natural ligand for the NPR-B receptor. Both receptors 
contain a kinase-like domain in their intracellular portion, followed by a guanylyl cyclase 
catalytic domain. Binding of the NP to their receptors activates guanylyl cyclase, leading 
to an elevation in intracellular cyclic guanosine monophosphate (cGMP).  
The NPR-C receptor is structurally different from the other receptors and does not contain 
an intracellular guanylyl cyclase catalytic domain. It is involved in clearance of the 
peptides. All the NP are able to bind to it with equal affinity and are subsequently 
internalized and enzymatically degraded. Besides its regulatory function, this receptor is 
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discussed to mediate inhibition of adenylyl cyclase activity and activation of phospholipase 
C activity (Palaparti et al., 2000).  
NPR-A Kinase domain Guanylyl cyclase
NPR-B Kinase domain Guanylyl cyclase
NPR-C             
ANP
BNP
CNP
ANP
BNP
CNP
Extracellular Intracellular
cGMP
cGMP
cAMP
Cell
membrane  
figure 5: Natriuretic peptide receptors (NPR). After extracellular binding at NPR-A and –B 
receptor, intracellular cGMP is elevated by a guanylyl cyclase domain. NPR-A binds ANP and 
BNP, whereas NPR-B binds CNP. NPR-C clears NPs and exerts other biological effects. 
The receptors are widely distributed in mammalian tissue with predominance in the 
cardiovascular system, adrenal glands and kidney (Silberbach et al., 2001). Additionally, 
all three receptors have been identified in the liver (Vollmar et al., 1997). 
5.3 cGMP-dependent signaling 
After receptor binding and intracellular formation of cGMP by guanylyl cyclases, cGMP 
exerts its regulatory functions by interacting with various cGMP receptor proteins (figure 
6): 
1. In various cell types, the effects of cGMP are mediated by cGMP-dependent 
protein kinases (PKG) (Lohmann et al., 1997; Pfeifer et al., 1999). 
2. In higher concentrations, cGMP is able to cross activate cAMP-dependent protein 
kinases (PKA) (Cornwell et al., 1994). 
3. A more common pathway by which cGMP utilizes the cAMP pathway is initiated 
by binding of cGMP to specific classes of phosphodiesterases (PDE), the 
enzymes responsible for the breakdown of cAMP and cGMP. Both a cGMP-
stimulatable PDE (type III) and a cGMP-inhibitable PDE (type II) are present in 
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various cells, where they can cause a decrease or an increase of cAMP levels in 
response to cGMP (Lincoln et al., 1993). 
4. In some tissues cGMP is known to regulate ion channels by direct allosteric 
interaction. A cGMP-gated channel was detected in heart and also in kidney, 
where it may contribute to the cGMP mediated natriuresis (Biel et al., 1998). 
TARGET
cGMP-dependent 
protein kinase
cAMP-dependent 
protein kinase
cGMP-regulated 
phosphodiesterase
cGMPcAMP
 
figure 6: Potential pathways by which cGMP may exert its physiological effects (for details see 
text). 
5.4 Cyclic nucleotide dependent protein kinases 
In this thesis, the contribution of PKG and PKA in ANP mediated hepatoprotection was 
investigated. Both enzymes are discussed to have beneficial effects in hypoxia related cell 
injury:  
The calcium lowering potential of ANP activated PKG with subsequent vasodilation was 
proposed to protect ischemic kidneys (Shaw et al., 1987; Nakamoto et al., 1987) and 
hypoxic hepatocytes (Pella, 1991; von Ruecker et al., 1989). 
Cyclic adenosine monophosphate activated PKA and prevented livers from IRI in a model 
of cold ischemic and reperfused rat livers (Akbar et al., 2001) and showed protective 
properties against apoptotic cell death in isolated cells (Li et al., 2000). 
cGMP-dependent protein kinases (PKGs) as well as the cAMP-dependent protein kinases 
(PKAs) belong to the large superfamily of protein kinases (Francis et al., 1994; Francis et 
al., 1999). These enzymes regulate the activity of numerous proteins by catalyzing the 
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transfer of the γ-phosphoryl group of ATP to the hydroxyl group of serine or threonine 
residues of an acceptor substrate protein.  
5.4.1 cGMP-dependent protein kinases 
Two isoenzymes of cGMP-dependent protein kinases (PKG I and II) have been identified 
in mammals (reviewed in (Pfeifer et al., 1999; Vaandrager et al., 1996; Francis et al., 
1994; Francis et al., 1999)). Both isotypes have been cloned, and were shown to exhibit a 
sequence homology of more than 50%, and a similar structural organization. PKG I is 
predominantly a cytosolic protein, whereas PKG II is tightly bound to the plasma 
membrane. They represent homodimers consisting of monomeric subunits with a 
molecular mass of 77 kDa (PKG I) and 87 kDa (PKG II), respectively. These kinases are 
composed of a regulatory and a catalytic domain. Alternative splicing of the amino 
terminus results in two isofoms of PKG I, i.e. PKG Iα and PKG Iβ, which differ both in their 
length as well as in their affinity to cGMP. Their mode of action is as follows: cGMP 
binding inside the regulatory domain results in a conformational change. The substrate 
interacts with the substrate binding domain inside the catalytic domain and a phosphate 
residue of ATP is transferred onto serine or threonine of the substrate.  
The tissue distribution of PKG I is highest in Purkinje cells of the cerebellum (Lohmann et 
al., 1981), platelets (Waldmann et al., 1986), and smooth muscle cells (Keilbach et al., 
1992). Likewise, cGK I is expressed in the kidney (Joyce et al., 1986), in endothelial cells 
of blood vessels (Draijer et al., 1995), neutrophil granulocytes (Lincoln et al., 1993), and 
macrophages (Pryzwansky et al., 1995). Among other sites, PKG II is highly expressed in 
intestinal epithelial cells (Markert et al., 1995), in brain (el Husseini et al., 1995) and 
kidney (Gambaryan et al., 1996), pointing to a regulatory function of ion transport in these 
organs. 
Interestingly, there is no unequivocal information available of PKG expression in the liver. 
The physiological role of PKG activation comprises modulation of secretory processes in 
kidney and intestine. In the latter, the activation of PKG II by Escherichia coli enterotoxin 
stimulates chloride and water secretion leads to the clinical symptoms of diarrhea 
(Vaandrager et al., 1997). In the kidney, PKG II is able to inhibit secretion and expression 
of renin, thereby affecting regulation of blood pressure, pointing to an ANP mediated 
effect (Wagner et al., 1998). Additionally, the effect of ANP to increase glomerular filtration 
rate could be accounted for by the localization of PKG I in mesangial cells (Singhal et al., 
1989) and smooth muscle cells of the vasculature (Joyce et al., 1986). Vasorelaxation by 
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decreasing intracellular Ca2+ is also involved in regulation of vascular tonus and blood 
pressure. Platelets express high amounts of PKG I and are regulated by nitric oxide (NO) 
via intracellular formation of cGMP (Moro et al., 1996). Adhesion, activation and 
aggregation are inhibited by this pathway (Radomski et al., 1987). In bones, PKG II was 
shown to have important influence in longitudinal bone growth (Yasoda et al., 1998). 
Although identified in a lot of tissues, the functions of PKGs are still poorly understood and 
need further investigation. 
5.4.2 cAMP-dependent protein kinases 
cAMP-dependent protein kinase (PKA) is present in all mammalian tissues investigated, 
including the liver (Kosmopoulou et al., 1994), and, in general, in higher concentrations 
than PKGs (Francis et al., 1999). In contrast to PKG, the regulatory (R) and catalytic (C) 
domain of PKA is localized on different polypeptide chains. In its inactive form, PKA is 
available as a tetramer, consisting of two regulatory and two catalytic domains. Binding of 
cAMP leads to the dissociation of the tetramer and to the release of two active catalytic 
subunits that are responsible for transfer of the γ-phosphoryl groups (Shoji et al., 1983; 
Takio et al., 1984; Titani et al., 1984). 
Two major R subunit isoforms (R I and R II with 43 and 45 kDa), also referred to as PKA I 
and PKA II, have been identified as products of different genes and within these isoforms 
there are still further distinctions. Three isoforms of the C subunit (40 kDa) are known that 
form with the R subunits the complete enzyme. The PKA I complex is rather cytosolic 
compared with PKA II complex, which is almost exclusively particulate associated. 
Expression of R I and R II varies with the species and tissue distribution. R Iα is 
expressed in many tissues, and R IIβ is more selectively expressed (Francis et al., 1999). 
The physiological importance of these variations is unclear (Doskeland et al., 1993). 
PKA in general is involved in an array of metabolic processes including gluconeogenesis, 
glycogenolysis and lipogenesis, as well as secretory processes, muscle contraction, 
learning, ion channel conductance, pro inflammatory cytokine production and action, 
differentiation, growth control, and apoptosis, for example (Houslay et al., 1997). 
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6. The heme oxygenase system 
The heme oxygenase-1 isozyme of the heme oxygenase enzyme family was investigated 
because of its emerging role in oxidant related cell injury (Immenschuh et al., 2000). 
6.1 Biological functions 
The 32 kDa heme oxygenase (HO) is the enzyme responsible for the physiological heme 
degradation (Tenhunen et al., 1968). In combination with the rate limiting enzyme of heme 
biosynthesis, δ-aminolevulinate synthase, HO regulates the cellular content of the pro-
oxidant heme and produces catabolites with physiological functions (Maines, 1997). It 
decomposes protoheme IX that is released mainly from hemoglobin of senescent 
erythrocytes, by cleaving its α-methene bridge to generate biliverdin-IXα, divalent iron, 
and carbon monoxide (CO). In most mammalian species, biliverdin is subsequently 
reduced to bilirubin by biliverdin reductase (figure 7). 
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figure 7: The heme oxygenase enzyme reaction. Scheme of catalytic conversion of heme into 
bilirubin, carbon monoxide (CO), and iron. 
Three genetically distinct isoforms are known in mammals (HO-1, -2, -3). HO-1 is widely 
distributed in tissues with highest occurrence in spleen and liver. It is highly inducible by 
various stimuli including, heavy metals, ROS, its substrate, protoheme IX, and heat, which 
lead to the term heat shock protein 32 (HSP-32). In the liver, HO-1 has been shown to be 
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constitutively expressed in Kupffer cells (Makino et al., 2001). Induction has been reported 
predominantly for hepatocytes (Paxian et al., 2001; Terajima et al., 2000; Rizzardini et al., 
1998). HO-2 is constitutively active but not inducible. It is present in highest 
concentrations in the brain and testes of mammals. HO-3 is nearly devoid of catalytic 
capability and may function as a heme sensing or a heme binding protein (McCoubrey, Jr. 
et al., 1997). 
6.2 Heme oxygenase-1 in oxidant stress 
Growing evidence supports an important role for HO-1 in protecting cells from oxidative 
stress (Choi et al., 1996; Immenschuh et al., 2000). The protection afforded by HO-1 
seems to be due to a reduction of heme concentrations and even more importantly to the 
production of biliverdin and bilirubin, both potent antioxidants (Stocker et al., 1987; Clark 
et al., 2000). The generated iron, although itself a potential prooxidative mediator via 
production of ROS by Fenton chemistry, stimulates biosynthesis of ferritin, a regulator of 
intracellular iron state. Its iron sequestering properties were shown to prevent cells from 
iron mediated cytotoxicity (Vile et al., 1993; Vile et al., 1994). In addition, it has been 
demonstrated that HO-1 induction protects cells by augmented cellular iron efflux (Ferris 
et al., 1999). The third reaction product, the signaling gas carbon monoxide (CO), has 
also been shown to be physiologically relevant. By formation of cGMP it is involved in the 
maintenance of vascular blood flow. In the liver, it has been demonstrated to protect the 
hepatic microcirculation under stress conditions (Suematsu et al., 2000) and, moreover, to 
have vasodilatant properties in the cardiovascular system (Sammut et al., 1998). 
6.3 Heme oxygenase-1: significance in IRI 
There is increasing evidence that induction of HO-1 in IRI of the liver exerts protective 
properties on organ function. Upregulation of HO-1 protected genetically fat rat livers from 
IRI. The organs showed significantly improved liver function, decreased hepatocyte injury, 
and extended animal survival in transplantation experiments (Amersi et al., 1999). 
Additionally, HO-1 expression could be induced by preconditioning of livers with the 
chemotherapeutic doxorubicin, a compound known to generate free radicals. The 
preconditioned livers were subsequently more resistant to IRI than untreated rat livers, 
which was attributed to HO-1 induction (Ito et al., 2000). Finally, hyperthermic 
preconditioning, i.e. sublethal heat exposure before a surgical intervention, rendered livers 
less susceptible to warm ischemia and was accompanied by increased HO-1 protein 
expression (Terajima et al., 2000). 
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7. The isolated perfused rat liver: general aspects 
For the evaluation of hepatic ischemia reperfusion (I/R) injury several experimental 
models have been established. Among them are cell culture models of parenchymal and 
non-parenchymal liver cells, in vitro liver perfusion models, and in vivo models of warm 
and cold ischemia and reperfusion (Clavien et al., 1992) (Post et al., 1996). 
Cell culture experiments with isolated liver cells are suitable, for example, to investigate 
changes of ion homeostasis during ischemia-reperfusion (Brecht et al., 1994). 
Microcirculatory disturbances, a major determinant of reperfusion injury, in contrast, can 
not be evaluated with cultured cells. Additionally, the missing interaction of liver cell 
populations is another major drawback of this method. 
To study the pathomechanisms of hepatic reperfusion injury, mainly in vivo models of I/R 
were applied. The participation of microcirculatory disturbances (Menger, 1995) and 
Kupffer cell activation (Jaeschke, 1996) were clarified on the basis of these models. 
Furthermore, pharmacological strategies to protect from I/R injury are based on 
transplantation models. The disadvantage of such complex models is the difficulty to 
distinguish between hepatic and extrahepatic mechanisms affected by a specific 
intervention. Simplification of the experimental setting can thereby be beneficial. 
The ex vivo model of the isolated perfused rat liver which is used in this investigation has 
to be seen in between the artificial cell culture system and the in vivo situation. Substantial 
information about I/R injury has been gathered from this technique. Extrahepatic factors of 
cell damage are missing and the resulting damage is solely caused by hepatic factors. A 
main advantage is the maintenance of liver architecture, rendering it a feasible model for 
the study of interactions between parenchymal and non-parenchymal cells (Jaeschke et 
al., 1990). The isolated perfused rat liver is a well established model for studies on hepatic 
metabolism. Steady state conditions allow the calculation of metabolic flux rates. As the 
polarity of the cells is maintained, sinusoidal uptake, metabolism, and biliary excretion of 
substances can be studied (Vom Dahl et al., 1997). In addition, substances can be 
investigated on their hepatoprotective or toxic properties. Major insight into the 
pathomechanisms of IRI in the liver were gathered from this model (Lemasters et al., 
1995), rendering it useful to investigate the mechanisms of ANP cytoprotection in IRI. Due 
to the application of blood-free perfusion buffers, however, the experiments can only be 
performed for about 3 to 5 h. This restricts the investigation of cell damage to the ischemic 
period and the early reperfusion phase. 
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B. Materials and Methods 
1. The isolated perfused rat liver 
1.1 Animals 
For isolated liver perfusion and primary hepatocyte isolation male Sprague-Dawley rats 
weighing 200–300 g were purchased from Charles River Wiga GmbH (Sulzfeld, Germany) 
and housed in a climatized room with a 12 h light-dark cycle. The animals received 
humane care and had free access to chow (Ssniff, Soest, Germany) and water up to the 
time of experiments. The study was registered with the local animal welfare committee. 
1.2 Solutions 
Krebs-Henseleit buffer (KH-buffer)  
NaCl 118 mM 
KCl 4.8 mM 
KH2PO4 1.2 mM 
MgSO4 x 7 H2O 1.2 mM 
NaHCO3 25 mM 
CaCl2 1.5 mM 
pH 7.4  
  
1.3 Model of the isolated perfused rat liver 
After anaesthetizing male Sprague-Dawley rats with Narcoren (Merial, Halbergmoos, 
Germany, 50 mg/kg body weight, intraperitoneally), 250 IU heparin were administered via 
the vena femoralis to prevent clotting. At sustained blood circulation, the portal vein was 
cannulated with a 16 gauge polyethylene tube (Insyte-W, BD, Heidelberg, Germany) and 
the liver was perfused in situ with Krebs-Henseleit (KH) solution. The perfusion medium 
was pumped instantly through the liver with a membrane pump (Prominent beta/4, 
Heidelberg, Germany) in a non-recirculating fashion (32 ml/min). For sufficient drain of 
perfusate the aorta abdominalis was incised and thorakotomie was performed to 
cannulate the vena cava inferior via the right atrium. To achieve complete perfusion of the 
organ, the vena cava inferior was ligated above the kidney vein and below the liver vein. 
Thereby, the venous liver perfusate was exclusively drained via the canula in the vena 
cava inferior. The liver was completely isolated from the cadaver to allow quick procedure 
for ischemic storage. For collection of bile fluid a polyethylene tube (length: 5 cm, inner 
diameter: 0.4 mm, total inner volume: 6 µl, Sims Portex Ltd., Hyte, UK) was placed in the 
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ductus choledochus. 
The perfusate flow rate was kept at 3.0 – 3.5 ml x min-1 x g liver-1. A hemoglobin and 
albumin free, bicarbonate buffered Krebs-Henseleit (KH) solution (pH 7.4) served as 
perfusion buffer, which was oxygenated by a tube oxygenator with carbogen gas (95% O2 
and 5% CO2, Linde, Unterschleißheim, Germany) and kept at a temperature of 37°C 
(Sies, 1978). The tube oxygenator consists of an aluminum block, winded with a silicon 
tube and placed in a plexiglas chamber. Substances were infused via infusion pumps 
(Braun Melsungen AG, Melsungen, Germany). Bubbles were removed from the perfusion 
buffer with a bubble trap (volume 10 ml). Bile and perfusate samples were collected 
during perfusion and kept on ice until analysis. Portal pressure rates before the liver were 
monitored on a hydrostatic column. 
A schematic illustration of the perfusion apparatus is shown in figure 8. 
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D. choledochus
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figure 8: The isolated perfused rat liver: schematic illustration. 
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1.4 Experimental setting 
1.4.1 Continous liver perfusion 
The perfusion model was validated according to Bilzer et al. (Bilzer, 1997). Livers were 
continuously perfused for up to 150 min. Lactate dehydrogenase activity was analysed to 
proof hepatocellular integrity (see 1.5.1). Bile production as indicator of liver function only 
slowly decreased and portal pressure remained constant during the perfusion period (see 
1.5.2 and 1.5.3). Oxygen saturation of the perfusate was checked with a blood gas 
analyser (Radiometer ABL505, Copenhagen, Denmark). The results demonstrated a 
successful surgery and a functioning perfusion apparatus (data not shown). 
1.4.2 Model of cold ischemia and reperfusion 
After 30 min of perfusion with KH buffer, livers were perfused with 30 ml of cold (4°C) 
University of Wisconsin (UW) solution (Viaspan, DuPont Pharma GmbH, Bad Homburg, 
Germany) for 1 min. The organs were then kept in 100 ml UW solution at 4°C for 24 h. 
Following the period of ischemia, livers were reperfused with KH buffer for 2 h at a flow 
rate of 3.0 – 3.5 ml x min-1 x g liver-1. At the indicated times, i.e. before ischemia, at the 
end of ischemia and after 45 and 120 min of reperfusion livers were snap-frozen in liquid 
nitrogen and stored at –80°C (Herafreeze, Heraeus, Hanau, Germany) until further 
analysis. Unless stated otherwise, 4–5 independent experiments were performed.  
Generation 
of samples:
Ischemia: 
UW-solution 24 h
10.-30. min
ANP or 
8-Br-cGMP
with ANP or 
8-Br-cGMP
Reperfusion: 
KH-buffer 45 min          120 min
Perfusion:
KH-buffer 30 min
 
figure 9: Experimental setting. 
1.4.3 Treatment protocols 
For treatment of livers, substances were dissolved in the respective dissolution medium 
and filled into Perfusor syringes (Braun Melsungen AG, Melsungen, Germany). They 
were placed into Perfusor maschines and flow rate was set according to the desired end 
concentration in the perfusate. 
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Treatment was performed by infusing ANP and 8-Br-cGMP to the pre-ischemic perfusate 
for 20 min until ischemia and to the storage solution at the same concentration. Enzyme 
inhibitors, depending on their mode of action, were partially infused for longer times (table 
1.1). 
Substances Vendor End-concentration Dissolution medium Infusion time 
ratANP 99-126 Calbiochem 
Mw 3062.5 
200 nM 0.9% NaCl solution 10.-30. min and cold 
ischemia 
8-Br-cGMP Sigma        
Mw 446.1 
50 µM H2O 10.-30. min and cold 
ischemia 
ZnPP Sigma        
Mw 446.2 
1 µM DMSO 10.-30. min and cold 
ischemia 
Rp-8-Br-cAMPS Biolog        
Mw 626 
1 µM H2O 0.-30. min and cold 
ischemia 
Rp-8-Br-pCPT-
cGMPS 
Biolog        
Mw 525.9 
1 µM H2O 0.-30. min and cold 
ischemia 
table 1.1: Substances for liver treatment 
Control experiments for the ZnPP perfusion set were performed by infusion of the same 
DMSO concentration into the perfusate (0.3% (v/v)). 
1.5 Parameters of liver function 
1.5.1 Lactate dehydrogenase efflux 
Lactate dehydrogenase (LDH) efflux into the perfusate is a sensitive indicator of cell 
damage in the isolated perfused rat liver (Sies, 1978). The activity measurement is based 
on the conversion of pyruvate to lactate by LDH. Reduction equivalents in form of NADH 
are thereby oxidized to NAD+ (Bergmeyer HU, 1974) resulting in a decrease in NADH 
extinction. 
Test preparation 
K2HPO4 (50 mM)/KH2PO4 (50 mM), pH 7.5 500 µl
Pyruvate (60 mM) 10 µl
NADH (10 mg/ml) 10µl
Liver perfusate 500 µl
 
The extinction was continuously monitored by a plotter. Enzyme activity was calculated 
based on the decrease in NADH extinction (ε365=3.34 mM-1cm-1). 
1.5.2 Bile efflux 
Bile was collected during the experiment and volumetrically quantified with a 100 µl 
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Hamilton microliter syringe (Bonaduz, Switzerland). The bile flow was calculated per min 
and g liver tissue. 
1.5.3 Portal pressure 
The portal pressure as parameter for hepatic circulation disturbances was monitored via a 
calibrated glass tube, connected to the portal catheter via the bubble trap. At the end of 
perfusion the liver was removed and the measured pressure was subtracted from the 
portal pressure during perfusion. 
2. Liver cell culture 
2.1 Animals 
Animals were purchased and housed as described under 1.1. 
2.2 Solutions 
All solutions were prepared with double destilled H2O and were subsequently autoclaved 
or sterile filtrated. 
PBS (phosphate buffered saline) 
Na2HPO4 1.48 g
KH2PO4 0.43 g
NaCl 7.20 g
H2O ad 1000 ml
Adjusting pH to 7.4 
 
Solution A 
NaCl 115 mM
NaHCO3 25 mM
KCl 5.9 mM
MgCl2 x 6 H2O 1.18 mM
NaH2PO4 1.23 mM
Na2SO4 1.2 mM
HEPES 20 mM
EGTA 0.5 mM
 
Solution B 
NaCl 115 mM
NaHCO3 25 mM
KCl 5.9 mM
MgCl2 x 6 H2O 1.18 mM
NaH2PO4 1.23 mM
Na2SO4 1.2 mM
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CaCl2 x 2 H2O 2.5 mM
HEPES 20 mM
EGTA 0.5 mM
Collagenase H  0.05%
in sterile H2O, adjusting to pH 7.35  
  
Percoll gradient  
NaCl 136 mM
Na2HPO4 x 2 H2O 10.2 mM
KCl 2.68 mM
KH2PO4 1.46 mM
MgCl2 x 6 H2O 0.5 mM
Perkoll solution 50% (v/v)
  
Hanks’ balanced salt solution (HBSS)  
CaCl2 x 2 H2O 0.95 mM
KCl 5.3 mM
KH2PO4 0.44 mM
MgCl2 x 6 H2O 0.49 mM
MgSO4 x 7 H2O 0.41 mM
NaCl 136.75 mM
Na2HPO4 x 2 H2O 0.34 mM
HEPES 20 mM
Adjusting pH to 7.35  
  
Medium199 (Pan Biotech, Aidenbach, Germany) supplemented with:
Glucose 8.3 mM
Glutamin 2 mM
Dexamethason 2.5 µg/ml
Penicillin G 100 U/ml
Streptomycin 100 µg/ml
BSA 50 µg/ml
Insulin 125 U/l
HEPES 10 mM
Addition of 5% (v/v) foetal calf serum (FCS) for 4 h precultivation
 
Trypan blue solution  
Trypan blue 0.08 g
NaCl 0.03 g
H2O ad 20 ml
  
  
2.3 Cultivation 
Cultivation was performed in a cell incubator (Heracell, Heraeus, Hanau, Germany) at 
37°C, 90% air humidity and 5% CO2. 
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2.4 Isolation of primary hepatocytes 
Isolation of primary rat hepatocytes was performed using the modified two step 
collagenase digestion method (Seglen, 1973) (Immenschuh et al., 1998) (de Groot et al., 
1991). Collagenase resolves the extracellular matrix of the liver tissue and the following 
cell suspension is separated via a Percoll density gradient centrifugation. Hepatocytes 
have the highest density among liver cells and can therefore be separated at low 
centrifugation force. 
Male Sprague-Dawley rats weighing 200 – 300 g were anaesthetized by intraperitoneal 
injection of Narcoren (50 mg/kg body weight). All instruments were autoclaved or heat 
sterilized to reduce germ contamination. Additionally, the body was rinsed with ethanol 
70% (v/v). 250 IU heparin were administered via the vena femoralis to avoid clotting. After 
opening the abdomen, the portal vein was cannulated with a 16 gauge polyethylene 
catheter (Insyte-W, BD, Heidelberg, Germany) and perfused with Ca2+ free solution A to 
resolve desmosomes by deprivation of Ca2+. Perfusate flow was established by a roller 
pump (Watson Marlow 101U/R, Falmouth, UK) at 30 ml/min. The perfusate was 
oxygenated with carbogen (O2 95%, CO2 5%, Linde, Unterschleißheim, Germany) and 
was kept at 37°C. By incision of the aorta abdominalis, a sufficient drain for the perfusate 
was ensured. After thorakotomia, the vena cava inferior was cannulated via the right heart 
atrium. The vena cava inferior was ligated above the kidney vein and below the liver vein 
to prevent outflow of perfusate. After the liver was flushed blood free for 4 to 7 min with 
solution A, collagenase H (Roche Diagnostics, Mannheim, Germany) containing buffer B 
was perfused. The cannulas were connected via silicon tubes to obtain a recirculating 
system. 
After further 6 to 8 min, the liver showed an increasing number of small rips, indicating the 
digestion of extracellular collagen matrix. The liver was carefully excised and rinsed with 
Ca2+-containing medium B. The following working steps were performed in a laminar flow 
work bench (Herasafe, Heraeus, Hanau, Germany). The digested liver was placed into a 
Petri dish and solution B was added. Liver cells were isolated by teasing the liver capsule 
apart and carefully scratching out the cells with a spoon. The cell suspension was filtrated 
with a Falcon cell strainer (100 µM, BD Labware, Bedford, MA, USA) and sedimentation 
of cells was allowed for 10 min. The supernatant was removed and the cell suspension 
was stratified onto a Percoll 50% solution (Amersham Pharmacia Biotech, Upsala, 
Sweden) into a 50 ml centrifugation tube. After centrifugation at 650 x g for 10 min at 4°C 
the 3 layers in the supernatant were removed and the remaining pellet, consisting of 
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hepatocytes, was resuspended in solution B. Cell number and vitality was checked in a 
Neubauer counting chamber. Addition of trypan blue solution (500 µl trypan blue solution, 
450 µl buffer B, 50 µl cell suspension) permitted counting of dead cells and calculation of 
cell vitality. After the isolation procedure, vitality was always larger than 80%. The 
hepatocytes were cultivated in collagen R coated (0.2 mg/ml, Serva, Heidelberg, 
Germany) 6-well cell culture plates (Peske, Aindling-Pichl, Germany) at a concentration of 
106 cells/ml. The cells were seeded in 1.5 ml medium containing FCS. After 4 h, cells 
were made quiescent by changing to medium without FCS. To remove cell debris and 
detached cells, the plates were washed twice before each medium change with HBSS. 
Cells were used for experiments 48 h later, whereby medium was changed after 24 h and 
26 h. After the indicated treatment time, the medium was removed, the plates were 
washed twice with PBS and stored at –80°C. 
2.5 Isolation of Kupffer cells 
Isolation of Kupffer cells was performed by Dr. A. K. Kiemer, Department of Pharmacy, 
University of Munich, Germany. 
Rat Kupffer cells (KC) were isolated according to the method of Knook et al. (Knook et al., 
1976) with some modifications (Armbrust et al., 1993). Briefly, the animals were 
anesthetized with an intraperitoneal injection of sodium pentobarbital (50 mg/kg body 
weight). The liver was first perfused in situ after cannulation of the portal vein with 100 ml 
Gay´s balanced salt solution (GBSS), then digested by perfusion with pronase and 
pronase/collagenase-solutions. The obtained cells were suspended in a 
pronase/collagenase-solution, shaken carefully for 30 min and passed through a 100 µm 
sieve. The hepatocytes were separated by differential centrifugation and the remaining 
nonparenchymal cells were separated by a Nycodenz-gradient. The density gradient 
centrifugation was performed at 1500 x g for 15 min. The cells of the interphase were 
collected and separated according to size by counterflow elutriation using a Beckman-
centrifuge (J 2-21, JE-6B rotor, Beckman Instruments, Munich, Germany). The obtained 
KC were sedimented, resuspended in culture medium (M 199, 15% FCS, 100 U 
penicillin/ml, 100 µg streptomycin/ml) and counted in a Fuchs-Rosenthal chamber after 
Trypan Blue-staining. Cells were then seeded at a density of 500 000 cells/well in 24-well 
or 2,25 x 106 cells/well in 6-well tissue plates and cultivated for 1 to 3 days. Two hours 
after plating, the cultures were washed to eliminate non-adherent cells. Cultures were kept 
in a 5% CO2-atmosphere and saturated humidity at 37°C. KC purity was determined using 
a fluorescent isothiocyanate (FITC)-labeled antiserum against ED2 and fluorescence 
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microscopy and by measuring phagocytosis of coumarin-conjugated latex beads by FACS 
analysis (FACScan, Becton Dickenson, San Jose, CA, USA). Preparations of KC were 
found >90% pure as judged by flow cytometry. 
3. Isolation of ribonucleic acids 
3.1 Extraction of ribonucleic acids 
total RNA (totRNA) was isolated using the guanidine thiocyanate/cesium chloride method 
according to (Chirgwin et al., 1979). 
The decomposition of RNA by the extraordinarily stable ribonucleases (RNAses) was 
prevented by addition of RNAse inhibiting substances (mercaptoethanol, guanidine 
thiocyanate). Moreover, solutions were prepared with double distilled and autoclaved 
water. All work was performed wearing plastic gloves. Glassware was sterilized for 3 h at 
180°C and solutions and plastic ware were autoclaved for 20 min at 121°C and 2 bar. 
Livers were homogenized in a guanidine thiocyanate solution and stacked onto a cesium 
chloride solution. By ultracentrifugation RNA is separated from DNA and proteins. 
Because of its higher density in comparison to other cell components RNA is collected as 
a pellet at the bottom of the centrifugation tube. 
3.1.1 Solutions 
Guanidine thiocyanate solution 
Guanidine thiocyanate 47.24 g
Tris-HCl pH 7.5 ad 100 ml
Addition of 1% (v/v) mercaptoethanol shortly before use
 
Tris/EDTA buffer (TE buffer) 
Tris-HCl pH 7.5 10 mM
EDTA pH 8.0 1 mM
 
3.1.2 Guanidine thiocyanate/cesiumchloride-method 
100 mg pieces of frozen livers were homogenized in guanidine thiocyanate solution with a 
Ultraturrax (Ika Labortechnik, Staufen, Germany) for 30 sec on highest stage. Besides 
homogenization, DNA is thereby sheared which results in a reduced viscosity of the 
solution. After addition of sodium lauroylsarcosine (final concentration 0.5%) the mixture 
was centrifuged for 5 min at 1,500 x g. The supernatant was stratified onto a 5.7 M cesium 
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chloride solution and centrifuged for 18 h at 40,000 x g in an ultracentrifuge (Sorvall 
Discovery 90, Hanau, Germany). 
The supernatant was removed, the pellet was washed with ethanol 70% (v/v) and dried for 
30 min at 45°C. The RNA was dissolved in TE buffer with SDS 0.1% (m/v) and 
precipitated by addition of 0.1 volumes of 3 M sodium acetate and 2.5 volumes of ice cold 
ethanol 100% at –70°C. For further processing, the samples were centrifuged at 12,000 
rpm (5 min, 4°C) and the resulting pellets were washed with ice cold ethanol 70% (v/v), 
dried, and dissolved in H2O. 
3.2 Measurement of nucleic acid concentration 
The determination of nucleic acid concentration is based on the absorption maximum of 
nucleic acids at 260 nm. The absorption caused by the aromatic ring system, is measured 
at 260 nm (A260) in quartz cuvettes of 1 cm of layer thickness. A solution containing 50 
µg/ml double stranded DNA under these conditions has an absorption of 1. Single 
stranded RNA contains 40 µg/ml at an absorption of 1. 
Aqueous RNA and DNA-solutions were determined in a Lambda Bio 20 photometer 
(PerkinElmer, Rodgau-Jügesheim, Germany). The purity of RNA was determined by 
measuring the A260/A280 ratio. Pure RNA has an A260/A280 ratio of 2.0. If RNA is 
contaminated with proteins, the ratio is significantly lowered (<1.8). 
3.3 Gel electrophoretic separation of nucleic acids 
Agarose electrophoresis is the standard method for separation and purification of DNA 
and RNA fragments. Because of their sugar phosphate backbone, nucleic acids are 
charged negatively and migrate towards the anode. The migration speed depends on their 
molecular weight and conformation. To resolve inter- and intra molecular hybridization and 
to linearize RNA, the denaturation of the molecules is necessary. This was performed by a 
denaturating glyoxal/DMSO gel electrophoresis, which leads to sharper bands in the 
following Northern blot analysis in comparison to formaldehyde gel (Thomas, 1980). 
The bands of ribosomal eucaryotic RNA can be detected under UV light (254 nm) after 
staining with the intercalating fluorescent dye ethidium bromide (EtBr). The two bands 
corresponding to the 28S and 18S sedimentation coefficients can be used as a criterion 
for the integrity of RNA. The ideal ratio of 2:1 indicates a successful isolation procedure. 
Additionally, mRNA should be visible as a diffuse fluorescence in the low molecular weight 
area. 
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3.3.1 Solutions 
Glyoxal-DMSO-phosphate (GDP) 
Glyoxal 6 M 200 µl
DMSO 595 µl
NaH2PO4 0.1 M pH 7.0 117 µl
H2O 300 µl
 
Loading buffer 
Glycerol 50% (v/v)
NaH2PO4 pH 7.0 0.01 M
Bromphenol blue 0.4 % (m/v)
 
To control the migration progress of the electrophoresis bromphenol blue was added to 
the sample buffer. This dye has the property to migrate like fragments of 10-100 bp of size 
and marks the front of electrophoretic movement. 
Ethidium bromide (EtBr) solution 
NH4-acetate 0.1 M 200 ml
NaOH 10 M 80 µl
EtBr 1 % (m/v) 80 µl
 
3.3.2 Agarose gel electrophoresis 
A 1.2% (m/v) agarose gel (Seakem LE, Biozym, Hessisch-Oldendorf, Germany) was 
prepared with 0.01 M NaH2PO4 in a horizontal gel chamber (Easycast, Owl separation 
systems, Portsmouth, NH, USA). 20 µg of RNA were dried in a SpeedVac Plus 
concentrator (Savant SC110A, Labsysteme Osvath, Geretsried, Germany) and denatured 
in 20 µl of GDP at 50°C for 1 h. To maintain the denaturation state the samples were kept 
on ice. After addition of 5 µl of loading buffer the total volume was pipetted into the gel 
slots and separated in 0.01 M NaH2PO4 pH 7.0 (80 V, 2.5 h, BioRad PowerPac 300). The 
formation of a H+ gradient in the electrophoresis buffer has to be prevented since local pH 
values larger than 8.0 may lead to a dissociation of the glyoxal RNA binding. Therefore, 
the electrophoresis buffer was recirculated with a Millipore roller pump during 
electrophoresis. 
3.3.3 Staining 
The gel was stained in ethidium bromide solution for 30 min. Excessive staining solution 
was removed by washing the gel in H2O for 15 min. Detection of intercalated dye was 
performed under UV light (254 nm) and imaged by a CCD camera system (Kodak image 
Station, Eastman Kodak Company, Rocester, New York, USA). 
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3.4 Separation of mRNA from totRNA 
In contrast to ribosomal RNA (rRNA) mRNA possesses a sequence of numerous 
adenosine bases at its 3’-end (poly(A)+-tail). This fact can be used for its isolation, which 
was performed with the PolyATract mRNA Isolation system (Promega, Heidelberg, 
Germany): mRNA was coupled to biotinylated oligo-deoxythymidin primers (Oligo(dT). 
This complex was bound to paramagnetic streptavidin particles via the streptavidin-biotin 
interaction and separated from the total RNA by magnetic forces. 
Total RNA at a concentration of 0.1-1.0 mg/500 µl H2O was denatured at 65°C for 10 min. 
150 pmol biotinylated Oligo(dT) primers and 20x SSC (see 4.5.1) were added and 
incubated at room temperature for 10 min to allow binding of the mRNA (polyA+) to the 
oligo(dT) primers. After washing the paramagnetic streptavidin particles (SA-PMP) 3 times 
with 0.5x SSC, the SA-PMPs were resuspended in 0.5x SSC and added to the 
RNA/oligo(dT) mixture with subsequent incubation at room temperature for 10 min. The 
oligo(dT) adsorbed RNA is thereby bound to the SA-PMPs via biotin – streptavidin 
interaction. After four washing steps with 0.1x SSC the mRNA was obtained by 
resuspending the mRNA-biotin bound SA-PMPs in H2O. The reduction of ionic strength 
resolves the mRNA from the biotin-SA-PMP complex, which is removed by a magnet. The 
resulting aqueous solution of RNA is finally centrifuged at 12,000 x g at 4°C for 5 min to 
eliminate all SA-PMPs. Quantification of the isolated mRNA was performed as described 
under 3.2. 
4. Northern blot 
HO-1 mRNA expression in rat livers was quantified by Northern blot analysis. totRNA was 
electrophoretically separated and transferred onto a nylon membrane. A radioactive cDNA 
probe complementary to the HO-1 mRNA sequence was hybridized to the expressed 
mRNA and was visualized by indirect autoradiography with intensifier screens 
(Phosphorimaging). 
4.1 Bacteria 
4.1.1 Strain 
For plasmid amplification, the bacteria strain Escherichia coli DH5α (Gibco/Invitrogen, 
Karlsruhe, Germany) was used. 
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4.1.2 Growth media and antibiotics 
Cultivation of bacteria was performed in LB-broth base (Lennox L Broth Base, 
Gibco/Invitrogen, Karlsruhe, Germany). After adjusting the pH-value to 7.5 with NaOH, the 
medium was autoclaved for 20 min at 1 bar and 121°C. 
Medium  
LB Broth Base 20 g 
Glucose 1 g
H2O ad 1000 ml 
  
For selection of successfully transformed bacteria containing plasmids with the β-
lactamase gene, ampicillin-sodium solution (in 70% ethanol) was added to the medium in 
a final concentration of 100 µg/ml. Only transformed bacteria express β-lactamase, which 
hydrolyses the β-lactame circle of ampicillin and this allows them to grow in presence of 
high concentrations of antibiotics.  
Selection of transformed bacteria was performed on ampicillin containing agar plates. 32 g 
LB agar (Lennox agar, Gibco/Invitrogen, Karlsruhe, Germany) and 1 g glucose were 
dissolved in 1 l of double distilled water, autoclaved and cooled to about 50°C. Ampicillin-
sodium (100 µg/ml) was added and the solution was filled into Petri dishes (Peske, 
Aindling-Pichl, Germany) and stored at 4°C. 
4.1.3 Cultivation 
E. coli was cultivated under aerobic conditions at 37°C in 10 ml tubes or 250 ml cell 
culture bottles (Peske, Aindling-Pichl, Germany) under vigorous shaking (300 rpm) in a 
Unihood 550 incubator (Uniequip, Martinsried, Germany). 
For short-term storage, LB-plates with bacteria colonies were kept at 4°C. 
4.2 Vectors 
4.2.1 Employed plasmids 
For preparation of a [α32P]-labeled cDNA probe for HO-1 Northern blot analysis, a pUC8 
plasmid (2,665 bp), with a 883 bp HO-1 insert was used (kindly provided by Dr. 
Immenschuh, Giessen). This plasmid contains a β-lactamase gene for selection in 
ampicillin-LB-medium and allows isolation of the insert by cutting with the restriction 
enzymes HindIII (Boehringer Mannheim, Mannheim, Germany) and EcoRI (Promega, 
Heidelberg, Germany). 
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In situ hybridization of HO-1 was performed by in vitro transcription of a pBluescript II 
phagemid vector (2,961 bp) with a 800 bp HO-1 insert (kindly provided by Dr. 
Immenschuh, Giessen). Selective growth is allowed by the inserted ampicillin resistance 
gene. This plasmid includes restriction sites for Bam HI (MBI Fermentas, St. Leon Roth, 
Germany) and Hind III (Boehringer Mannheim, Mannheim, Germany) in its multiple 
cloning site. Cutting by Bam HI allows run off transcription of the antisense probe with T3-
polymerase, whereas Hind III cleavage leads to generation of the sense probe by T7-
polymerase. 
4.3 Amplification of a cDNA-Northern blot probe 
4.3.1 Preparation of competent cells 
Competent bacteria are able to incorporate external DNA. Treatment with calcium chloride 
and rubidium chloride is one method to initiate this uptake. 
E. coli DH5α were cultivated in LB-medium (20 ml) at 37°C up to an optical density (OD600 
nm) of 0.3 to 0.5. Cells were centrifuged (5,000 rpm, 5 min, 4°C), the pellet was 
resuspended in 1 ml of ice cold solution A (3-[N-Morpholino]propansulfonic acid (MOPS) 
pH 7.0, 10 mM; rubidium chloride 10 mM), added up to 10 ml solution A and centrifuged 
again. The supernatant was discarded, the pellet resuspended in 1 ml solution B (MOPS, 
pH 6.5, 100 mM, calcium chloride 50 mM, rubidium chloride 10 mM) and after adding up 
to 10 ml with solution B, incubated on ice for 30 min. After centrifugation and gentle 
resuspensation in solution B, 10% glycerol was added and competent cells were storable 
at –70°C for several weeks. 
4.3.2 Transformation of competent E. coli 
Transformation of E. coli, the uptake of free external DNA into bacteria cells, was first 
described by Mandel and Higa (Mandel et al., 1970). 
100 µl of competent bacteria suspension were thawed on ice and incubated with 0.1 µg 
plasmid DNA for 30 min. The suspension was incubated at 42°C for 60 sec and 
transferred into 1 ml LB-medium. The mixture was again incubated at 37°C for 1 h, mixed 
and 20 µl or 200 µl, were plated onto LB-agar-ampicillin plates. The successfully 
transformed bacteria were able to grow overnight at 37°C in single colonies. 
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4.3.3 Mini-prep DNA isolation 
Success of transformation was controlled by picking single colonies of bacteria grown on 
LB agar ampicillin plates and propagating them. The plasmids were isolated by lysing the 
bacteria with lysozyme, Triton X-100 (non-ionic detergent), and heat. Chromosomal DNA 
thereby clings to the cell membrane and can be separated together with cell debris from 
plasmid DNA by centrifugation. The solved plasmid DNA is then precipitated by 
isopropanol and washed with ethanol 70% (v/v) to remove in isopropanol insoluble salts. 
The identification of the plasmid DNA takes place by gel electrophoresis. 
STET  
Sucrose 8% (m/v) 
Triton X-100 5% (m/v) 
Tris-HCl pH 8.0 50 mM 
EDTA 50 mM 
  
One single bacteria colony was incubated in a sterile 15 ml centrifugation tube in 2 ml 
LB/ampicillin overnight under vigorous shaking (300 rpm, 37°C) in a Unihood 550 
incubator (Uniequip, Martinsried, Germany). The next morning, 500 µl of the bacteria 
suspension were transferred to a sterile reaction tube and stored at 4 °C. The remaining 
bacteria suspension was centrifuged (100 x g, 5 min) and the supernatant removed. The 
bacteria pellet was resuspended in 200 µl STET. By addition of 16 µl lysozyme solution 
(10 mg/ml, sodium salt) and incubation at 75°C (60 sec) the bacteria were lysed. 
Centrifugation at 12,000 x g for 10 min separated the bacteria DNA (in the pellet) from the 
plasmid DNA (in the supernatant). Plasmid DNA was precipitated by addition of 
isopropanol 50% (v/v) (5min, RT) and after centrifugation at 12,000 x g for 10 min the 
pellet was washed with ethanol 70% (v/v). After a final centrifugation step (12,000 x g, 3 
min), the pellet was air dried and dissolved in 40 µl TE buffer and stored at –20°C until 
electrophoresis. 
4.3.4 Agarose gel electrophoresis 
Plasmid DNA was identified by electrophoresis in an 1% (m/v) agarose gel in 1x TBE-
buffer. 12 µl DNA solution were mixed with 3 µl commercial loading buffer (Promega, 
Heidelberg, Germany) and separated in 1x TBE electrophoresis buffer in a horizontal 
electrophoresis chamber at 80 V. 0.5 µg of known plasmid served as control. 
10x TBE (Tris borate EDTA)  
Tris 900 mM
Boric acid 889 mM
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EDTA 25 mM 
  
4.3.5 Midi-prep DNA isolation with Qiagen Plasmid Midi Kit 
Larger amounts of highly purified DNA for the preparation of a DNA Northern blot probe 
were isolated with the Quiagen Midi Kit (Quiagen GmbH, Hilden, Germany). This kit is 
based on the principle of alkaline lysis with consecutive chromatographic purification via 
anionic exchange columns. Thereby, DNA is separated from polysaccharides, RNA, and 
other contaminants. 
Bacteria were lysed with NaOH/SDS and proteins and DNA were denatured. The method 
is based on the fact that by neutralization with high concentrations of potassium acetate 
the relatively low molecular plasmid DNA again renatures, while proteins, DNA, and cell 
debris remain bound to salt/SDS complexes and can be separated by centrifugation. The 
following purification by anionic exchange columns removes salt- and protein impurities. 
By addition of isopropanol to the eluate the plasmid DNA is precipitated. 
  
Buffer P1  
Tris-HCl pH 8.0 50 mM 
EDTA 10 mM 
RNase A 100 µg/ml
 
Buffer QBT  
NaCl 750 mM 
MOPS pH 7.0 50 mM 
Ethanol 15% (v/v) 
Triton X-100 0.15% (m/v)
 
Buffer QC  
NaCl 1.0 M 
MOPS pH 7.0 50 mM 
Ethanol 15% (v/v) 
 
Buffer QF  
NaCl 1.25 M 
Tris-HCl pH 8.5 50 mM 
Ethanol 15% (v/v) 
 
STE (Sodium chloride Tris EDTA buffer) 
NaCl 100 mM 
Tris-HCl pH 8.0 10 mM 
EDTA 1 mM 
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The successfully transformed E. coli DH5α bacteria were cultivated in 50 ml LB/ampicillin 
to an optical density (600 nm) of 1 to 1.5 and centrifuged at 1,000 x g at 4°C for 15 min. 
The pellet was resuspended in 10 ml of buffer P1 and lysed with 4 ml 200 nM NaOH/1% 
(m/v) SDS (5 min, RT) followed by incubation on ice for 15 min with 4 ml ice cold 3 M 
potassium acetate pH 5.5. The pellet was separated by centrifugation (20,000 x g, 30 min, 
4°C) and the supernatant was cleared completely by centrifugation once more for 15 min. 
The supernatant was placed on a equilibrated Quiagen column (Quiagen-tip 100, with 4 
ml QBT buffer) and the column was washed twice with 10 ml buffer QC. The eluate was 
discarded and the DNA bound to the column eluted with 5 ml buffer QF. The DNA in the 
eluate was precipitated with 0.7 volumes of isopropanol. The resulting pellet after 
centrifugation at 15,000 x g (4°C, 30 min) was washed with 70% (v/v) ethanol and air 
dried. After resolving in H2O, concentration of DNA was determined according to 3.2. 
4.3.6 Restriction endonuclease digestion 
To obtain the inserted HO-1 DNA sequence for preparation of the radioactive probe the 
purified circular plasmid was cut with the restriction enzymes Eco RI and Hind III (see 
4.2.1). 
Reaction mixture  
Plasmid DNA 20 µg
Restriction enzyme 3 µl
Buffer 10 µl
H2O ad 100 µl
  
The reaction mixture was prepared on ice and incubated for 5 h at 37°C. To separate the 
restriction products an agarose gel electrophoresis was performed. The respective 
products were identified by comparison with a DNA ladder mix (GeneRuler DNA Ladder 
Mix, MBI Fermentas, St. Leon Roth, Germany). 
4.3.7 Extraction of DNA from agarose gels 
DNA fragments were extracted and purified from agarose gels with the QIAquick gel 
extraction kit from Qiagen (Hilden, Germany). Test principle is the adsorption of nucleic 
acids to a silica-gel membrane in presence of high salt concentration and a defined pH. 
Contaminants such as salts, enzymes, unincorporated nucleotides, agarose and dyes do 
not bind to the silica-gel membrane but flow through the column. 
To extract the HO-1 fragment, the corresponding lane was cut out of the agarose gel and 
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3 volumes of buffer QG was added to 1 volume of gel slice. The gel was solubilized by 
incubating the mixture at 50°C for 10 min. The yellow color of the solution indicated the 
correct pH value (<7.5). One volume of isopropanol was added and the sample was 
mixed. To bind DNA to a QIAquick spin column, the sample was applied to a column in a 
collection tube and was centrifuged for 1 min at 14,000 rpm. The flow through was 
discarded and after addition of 0.5 ml of buffer QG the column was centrifuged again. 
After washing with 0.75 ml of buffer PE the flow through was removed and the column 
was centrifuged for 1 min to separate residual ethanol. To elute the DNA from the silica-
gel membrane the column was placed in a clean reaction tube and 50 µl of H2O were 
added to the column before centrifugation. Under these conditions (pH 7-8.5 and low salt) 
maximum elution efficiency is achieved. Until further investigation the DNA was stored at 
–20°C. 
4.3.8 Sequencing of double stranded DNA 
The generation of the correct plasmid insert was confirmed by sequencing the isolated 
product by the company Toplab, Martinsried, Germany. Sequencing by the method of 
Sanger et al. (Sanger et al., 1977) revealed that the insert was identical with the 883 bp 
HO-1 sequence. 
4.4 DNA labeling with radioactive nucleotides 
4.4.1 Synthesis of radioactively labeled HO-1 cDNA 
Radioactive labeling of a DNA probe for use as hybridization probe in HO-1 Northern blot 
analysis was performed with the random primed DNA labeling kit from Roche (Roche 
Diagnostics GmbH, Mannheim, Germany). This method is based on the hybridization of a 
mixture of all possible hexanucleotides to the DNA to be labeled. [α32P]-dCTP is 
incorporated into the newly synthesized complementary DNA strand which is synthesized 
from the 3’-end-terminus of the random hexanucleotide primer using Klenow enzyme 
(Feinberg et al., 1983). 
The DNA had to be denatured by heating for 10 min at 100°C and subsequent cooling on 
ice. The following was added to a reaction tube on ice according to the instructions of the 
manual: 
Reaction mixture  
cDNA template 0.01-2 µg
dNTP’s (dATP, dGTP, dTTP) 1 µl 
Hexanucleotides in 10x buffer 2 µl 
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[α32P]-dCTP (Amersham) 50 µCi
Klenow enzyme 1 µl
H2O ad 20 µl
  
The mixture was incubated for 30 min at 37°C. The reaction was stopped by heating for 
10 min at 65°C. 
4.4.2 Synthesis of radioactively labeled 28S RNA oligonucleotides 
Radioactive labeling of a 28S RNA oligonucleotide probe to subsequently validate HO-1 
Northern blotting (Barbu et al., 1989) was made by the T4 polynucleotide kinase method. 
The T4 polynucleotide kinase (Stratagene, Heidelberg, Germany) catalyzes the transfer of 
the terminal [γ32P]-phosphate of ATP to the 5'-hydroxyl terminus of an RNA or DNA 
molecule (Richardson, 1965).  
28S RNA oligo probe: 5’-AAC GAT GAG AGT AGT GGT ATT TCA CC-3’ Barbu et al., 1989 
Reaction mixture 
28S RNA oligo probe 0.2 µg
T4 polynucleotide kinase buffer 10x 2 µl
[γ32P]-ATP  5 µl (3000 Ci/mmol)
H2O 10 µl
T4 polynucleotide kinase 2 µl (1 µl + 1µl dilution buffer)
 
The mixture was incubated at 37°C for 30 min. The reaction was terminated by heating 
the mixture to 65°C for 5 min. 
4.4.3 Removal of unincorporated dNTPs 
Removal of radioactively labeled probes from non incorporated [α32P]-dCTP or [γ32P]-ATP 
was performed on a NucTrap column (NucTrap probe purification column, Stratagene, 
Heidelberg, Germany). The free nucleotides remain on the column and the eluate 
contains the DNA probe. 
70 µl of STE (4.3.5) were added to the reaction mixture and placed onto a column which 
had been equilibrated with 70 µl STE. The solution was pressed through the column by 
the use of a syringe. This was repeated with 70 µl STE and finally with air. The eluate was 
collected in a reaction tube and the incorporation of radioactivity was measured in a β-
counter (Beckmann LS6500, Multi-purpose Scintillation Counter, Irvine, CA, USA). 1 µl of 
the mixture was added to 5 ml of szintillation cocktail (Rotiszint, Roth, Karlsruhe, 
Germany) and was counted in a channel set for [32P]. 2 x 106 cpm were required for 
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Northern hybridization. 
4.5 Northern blot 
For evaluation of HO-1 mRNA expression, Northern blotting was performed with a HO-1 
cDNA probe. Northern blot results were validated, by hybridization with a 28S RNA 
oligonucleotide probe. 
4.5.1 Solutions 
20x SSC (Saline sodium citrate)  
NaCl 175.3 g
Na-citrat 88.2 g
H2O ad 1000 ml 
Adjusting to pH 7.0  
 
Hybridization solution  
20x SSC 5 ml
50x Denhardt’s solution (Biomol) 2 ml
Formamide 50% (v/v) deionized 10 ml
SDS 1% (v/v) 2 ml
denatured salmon sperm DNA (100 µg/ml) 200 µl
H2O 800 µl
  
4.5.2 Transfer of electrophoretically separated RNA onto a nylon 
membrane 
Electrophoretically separated but unstained RNA (3.3.2) was transferred onto a nylon 
membrane by vacuum blotting (VacuGeneXL Vacuum blotting system, Amersham 
Pharmacia Biotech, Freiburg, Germany). This method is characterized by short transfer 
times (45-60 min) and quantitative transfer with high band sharpness and resolution. 
The nylon membrane (Nytran 0.2 µm, neutral, Schleicher and Schüll, Dassel, Germany) 
was soaked in 20x SSC and placed into the blotting apparatus according to the 
instructions of the manufacturer. The membrane was covered with the agarose gel and 
20x SSC was filled into the chamber. A vacuum of 50-55 mbar was established and kept 
for 45 min. After the transfer, the membrane was air dried and the RNA was UV-
crosslinked to the membrane (Stratalinker UV Crosslinker 1800, Stratagene, Heidelberg, 
Germany). By treatment with UV-light (254 nm), the uracil of RNA is covalently bound to 
amino residues of the nylon membrane. 
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4.5.3 Hybridization 
Hybridization of immobilized RNA with radioactively labeled DNA was performed as 
described by (Vollmar, 1990) in a hybridization oven from Uniequip (Martinsried, 
Germany). 
The blots were soaked in 20 mM Tris-HCl pH 8.0 for 5 min at 65°C to remove glyoxal 
traces. After washing in 6x SSC, the blots were rolled air bubble free into glass 
hybridization tubes and prehybridized at 42°C for 4 h in hybridization solution. After that 
time the radioactive cDNA probe was denatured for 5 min at 95°C and then added to the 
hybridization tubes. Hybridization was continued at 42°C overnight. The next day, the 
hybridization solution was removed and the blots were washed 2 times in 2x SSC/0.1% 
SDS at room temperature for 5 min. Afterwards, blots were washed 2 times in 0.2x 
SSC/0.1% SDS at room temperature for 5 min and 2 times in 0.2x SSC/0.1% SDS at 
42°C for 15 min. Before air drying, the blots were rinsed with 2x SSC. 
4.5.4 Detection  
Hybridization of radioactive labeled probes and mRNA was visualized by indirect 
autoradiography with intensifyer screens (phosphorimaging). High energetic β-radiation is 
adsorbed by phosphate residues of intensifyer screens and is transformed into blue light. 
The screens were scanned in a Fujifilm BAS-1500 (Raytest, Straubenhardt, Germany) for 
densitometric evaluation of radioactive signals. 
5. In situ hybridization 
The cellular expression pattern of HO-1 mRNA was investigated by in situ hybridization 
with a radioactive HO-1 RNA probe.  
In situ hybridization was performed by Dr. A. K. Kiemer in snap-frozen liver samples by a 
method described in detail by Milani et al. (Milani et al., 1994).  
5.1 Hybridization 
After treatment with 0.2 N HCl and washing in H2O, the slides were digested in pronase, 
rinsed in 0.1 M glycine/PBS, and fixed in 4% paraformaldehyde/PBS. Slides were then 
washed in PBS and acetylated. Washed slides were dehydrated in graded ethanols and 
air-dried prior to hybridization. Transcription and labeling of RNA probes were performed 
with [35S]Uridine-5'-(-thio)-triphosphate (NEN, Boston, MA, USA). Slides were incubated 
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with hybridization mixture at 50°C overnight. Excess of probe was removed by washing in 
hybridization buffer (4 h, 50°C). Slides were then digested with RNase and washed in 0.1 
M Tris-HCl pH 7.5/1 mM EDTA/0.5 M NaCl. After additional washing in 2x SSC and 0.1x 
SSC, slides were dehydrated in graded ethanols and air-dried.  
5.2 Detection 
Autoradiography was performed by dipping the dehydrated slides into Ilford G5 nuclear 
emulsion (Ilford, Mobberley Cheshire, UK) and exposing them for 28 days. Slides were 
developed and counterstained in hematoxylin-eosin. Sections from untreated and ANP-
treated livers were processed in parallel, using the same batches of probes (sense and 
antisense HO-1) and reagents. 
6. Reverse transcriptase polymerase chain reaction 
The expression of cGMP-dependent protein kinases (PKG) in rat livers was evaluated by 
the reverse transcriptase polymerase chain reaction (RT-PCR) technique. This in vitro 
technique was developed by Mullis et al. (Mullis et al., 1987) and allows the amplification 
of nucleic acid segments of defined length and sequence. For evaluation of mRNA 
expression, RNA had to be transferred into complementary DNA (cDNA) by reverse 
transcription first. 
6.1 Reverse transcription 
The reverse transcription was performed with viral reverse transcriptase from avian 
myeloblastosis virus (AMV-RT, and all other substances, Promega, Heidelberg, 
Germany). mRNA was used as preferred template for cDNA synthesis due to lower 
contamination compared to totRNA. 
Reaction mixture 
MgCl2 5 mM
Tris-HCl 10 mM
KCl 50 mM
Triton X-100 0.1% (v/v)
DNTP 1 mM
RNase inhibitor 5% (v/v)
Oligo(dT)15 primers 1% (v/v)
AMV-RT 15 U/1 µg mRNA
 
1 µg of mRNA was added to 10 µl reaction mixture. After incubation for 15 - 20 min at 
42°C, the reaction was terminated by boiling for 5 min. The samples were placed on ice 
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and stored at –20°C. 
6.2 Primers and reaction conditions 
All oligonucleotides were purchased from MWG Biotech (Ebersberg, Germany) and were 
HPLC purified.  
 
Gene Orientation Sequence Length Reference
PKG I human sense 5’-GGA GAC GTG GGG TCA CTG GTG-3’ 377 bp Lohmann, personal 
 antisense 5’-AAA GAA GGT GTC CCC TCT TGC-3’ communication
PKG II rat sense 5’-GTG GCC AGA TTC TCA ACC TC-3’ 542 bp Huber et al., 1998
 antisense 5’-ACC TCG GGG GCC ACA TAC TCT-3’  
GAPDH rat sense 5’-AGA TCC ACA ACG GAT ACA TT-3’  
 antisense 5’-TCC CTC AAG ATT GTC AGC AA-3’  
table 6.1: Primer sequences for RT-PCR. 
 Pretreatment Annealing Extension Denaturation Posttreatment Cycles
PKG I 70°C, 3 min 94°C, 40 sec 56°C, 40 72°C, 60 sec 72°C, 10 min 35
PKG II 70°C, 3 min 94°C, 40 sec 58°C, 40 72°C, 60 sec 72°C, 10 min 35
GAPDH 93°C, 60 sec 93°C, 30 sec 55°C, 30 73°C, 60 sec 73°C, 10 min 30
table 6.2: PCR reaction conditions. 
RT-PCR was set up using the respective primers according to table 6.1 and amplification 
was performed as listed in table 6.2.  
6.3 Polymerase chain reaction 
Reaction mixture  
BSA 1%  0.005% (m/v)
MgCl2 1.5 mM 
dNTP 1.0 mM 
10x Buffer 1x 
Primer sense 0.6 µg 
Primer antisense 0.6 µg 
H2O ad 100 µl 
cDNA sample 2 ng 
Taq DNA polymerase 2.5 U (was added after the first denaturation step)
  
The reaction mixture was prepared on ice in reaction tubes without the Taq DNA 
polymerase. For exclusion of unspecific amplification, samples without cDNA were 
additionally amplified. The thermocycler (Gene Amp PCR System 9700, PE Applied 
Biosystems, Foster City, CA, USA) was set up according to the cycle temperatures and 
times in table 6.2. After the first denaturation step (pre-treatment) the program was 
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interrupted in order to add the heat stable Taq DNA polymerase. This so called hot start 
method shows less unspecific products and reduces aggregation of primers to oligomers 
(Chou et al., 1992). Early misspriming cannot serve as Taq DNA polymerase starting 
point. Misspriming is reversed after the initial denaturation step and primers can hybridize 
correctly at their annealing temperature. Thereafter, cycles of annealing, extension and 
denaturation of the DNA strand were repeated as indicated in table 6.2. The posttreatment 
allowed to finalize incomplete amplification. 
6.4 Electrophoresis of amplification products 
For evaluation of amplification products, samples were separated by gel electrophoresis. 
A 2.5% agarose gel was prepared with TAE buffer (see 4.3.4). Samples and DNA ladder 
(GeneRuler DNA Ladder Mix, MBI Fermentas, St. Leon Roth, Germany) for estimation 
of PCR product size were mixed with loading buffer (MBI Fermentas) and 
electrophoretically separated (80 V, TAE buffer, 2 h). Staining with ethidium bromide took 
place as described under 3.3.3. 
Tris-acetate-EDTA buffer (TAE)  
Tris-acetate 40 mM 
EDTA 1 mM 
Adjusting pH to 8.0  
  
7. Detection of proteins by Western blotting 
Protein expression of Caspase-3 and HO-1 protein in rat livers was investigated by 
Western blot analysis. 
7.1 Preparation of samples 
7.1.1 Solutions 
Lysis buffer:  
NaCl 150 mM 
Tris-HCl, pH 7,5 50 mM 
Nonidet P 40 1%(v/v) 
Deoxycholate 0,25% (m/v) 
SDS 0,1% (m/v) 
  
Lysis buffer was supplemented with the protease inhibitor mix Complete (Boehringer 
Mannheim, Mannheim, Germany) before use according to the manufacturer’s instruction. 
5x Sample buffer  
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3.125 M Tris HCl pH 6,8 100 µl
Glycerol 500 µl
20% SDS 250 µl
16% DTT 125 µl
Pyronin Y 5 % 5 µl 
Aqua demin. 20 µl
  
7.1.2 Preparation of cellular protein extracts from rat liver tissue 
All work was performed in a 4°C cooling chamber. Livers were stored during the 
preparation procedure on dry ice. 100 mg of liver tissue was added to 1 ml of ice cold lysis 
buffer and homogenized by 10 strokes with a Potter S device (Braun Biotech, Melsungen, 
Germany). Afterwards, homogenates were centrifuged for 20 min at 4°C and 14,000 rpm. 
Clear supernatants were used for the following protein determination and protein 
electrophoresis. 
7.1.3 Preparation of cellular protein extracts from rat hepatocytes 
Hepatocytes were cultivated in 6-well cell culture plates. 200 µl lysis buffer containing 
Complete protease inhibitor mix were added per well and cells were lysed by scratching 
with a cell scraper. After transferring to reaction tubes, cell suspensions were treated with 
eight strikes of ultra sonic to smash DNA and therefore reduce viscosity. Afterwards, 
homogenates were centrifuged for 20 min at 4°C and 14,000 rpm. Clear supernatants 
were used for the following protein determination and protein electrophoresis. 
7.1.4 Preparation of samples for protein electrophoresis 
Before protein electrophoresis, protein samples were denatured and were charged 
negatively by addition of 5x sample buffer and boiling for 5 min. 
7.2 Measurement of protein concentration: Lowry-assay 
Protein content for Western analysis was determined according to Lowry (Lowry et al., 
1951) by photometric quantification. The final colour is a result of the Biuret reaction with 
copper ion in alkali and the reduction of phosphomolybdic and phosphotungstic reagent 
by tyrosine and tryptophan present in the peptide chains. 
Reagent A:  
Na2CO3 10 g 
NaOH 0.1 mol/L 500 ml
  
Reagent B:  
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Na/K tartrat 0.5 g 
CuSO4 0.25 g 
Aqua demin. 50 ml 
  
Reagent 1:  
Alkaline copper solution 50 parts of reagent A plus 1 part of reagent B
  
Reagent 2:  
Diluted Folin’s reagent  Folin-Ciocalteu’s phenol reagent - aqua demin. (1:1) 
  
The protein solution was diluted with Aqua demin. as necessary and 200 µl of sample was 
transferred into a reaction tube. 1 ml of reagent 1 was added, mixed well and incubated 
for at least 10 min at room temperature. 100 µl of reagent 2 were added subsequently, 
mixed well and incubated for at least 30 min. Absorbance was measured at 500 nm in a 
Lambda Bio 20 photometer, Perkin Elmer. By creating standard dilutions with bovine 
serum albumin (0-500 µg/ml), the corresponding protein concentration was determined. 
7.3 SDS-polyacrylamide gel electrophoresis (SDS-Page) 
Separation of proteins was performed by the denaturating SDS-polyacrylamide gel 
electrophoresis (SDS-Page) (Laemmli UK, 1970). The anionic detergent sodium dodecyl 
sulfate (SDS) solubilizes proteins and leads to a constant net charge per mass unit. 
Therefore proteins are separated exclusively according to their molecular mass. 
Differences in molecular form are compensated by the loss of the tertiary and secondary 
structure because of the disruption of the hydrogen bonds and unfolding of the molecules. 
Disulfide bonds are cleaved by the reducing thiol agent dithiothreitol (DTT). Molecular 
weight standard (Santa Cruz Biotechnology, sc-2035, Heidelberg, Germany) was used to 
determine the molecular weight of the separated proteins. 
Electrophoresis was carried out in a vertical apparatus from BioRad (Mini Protean II, 
Munich, Germany). Two gel runs were performed in parallel.  
7.3.1 Solutions 
For preparation of gels polyacrylamid (PAA)/bis-acrylamide stock solutions (Rotiphorese 
Gel 30) from Roth (Karlsruhe, Germany) were applied. 
Resolving gel 10 %: 
PAA solution 30% 6.25 ml
1.5 M Tris, pH 8.8 4.69 ml
10% SDS 0.188 ml
H2O 7.625 ml
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10 min degassing 
TEMED (Tetramethylethylenediamine) 18.75 µl
APS (ammonium persulfate) 10% (m/v) 93.75 µl
 
Stacking gel: 
PAA solution 30% 2.125 ml
1.25 M Tris, pH 6.8 1.25 ml
10% SDS 0.125 ml
H2O 8.75 ml
10 min degassing 
TEMED (cross linker) 25 µl
APS 10% (m/v) (radical starter) 125 µl
 
The solutions were degassed for 10 min by a vacuum pump to get anaerobic conditions 
for polymerization. After that, TEMED and APS were added. 
Electrophoresis buffer:
Tris 3 g
Glycine 14.4 g
SDS 1 g
H2O ad 1000 ml
 
7.3.2 Electrophoresis 
The stacking gel was placed about 2 cm above the resolving gel. The slot former was 
directly put into the stacking gel and complete polymerization was allowed overnight at 
4°C. The next day samples with equal protein content were filled up to 35 µl and pipetted 
into the slots. Additionally, molecular weight standard (3 µl + 32 µl sample buffer) was 
added. Stacking was carried out at 100 V for 21 min. The proteins were resolved at 200 V 
for 36 min (power supply: Biometra, Göttingen, Germany). 
7.4 Coomassie blue staining 
To check for equal sample loading and effective blotting gels were stained with 
Coomassie blue solution. 
7.4.1 Solutions 
Staining solution: 
Acetic acid (100%) 10% (v/v)
Ethanol (96%) 30% (v/v)
In H2O 
 
Destaining solution: 
Coomassie blue  0.3 %
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Acetic acid (100%) 10% (v/v)
Ethanol (96%) 45% (v/v)
In H2O 
Filtration 
 
7.4.2 Staining procedure 
After Western blotting, SDS-page gels were stained for 15 min in Coomassie staining 
solution. Then, gels were destained in destaining solution 3 times for 15 min and finally 
stored in H2O. 
7.5 Immunologic detection by Western blotting 
Proteins were transferred electrophoretically from the gel onto a polyvinylidenfluoride 
(PVDF) membrane (Immobilon-P, 0.45 µM pore size, Millipore, Bedford, MA, USA). To 
visualize the proteins of interest, a specific first antibody was bound to the immobilized 
proteins. By binding a second anti-immunoglobuline antibody labeled with horseradish 
peroxidase (HRP) to the first antibody, this complex can be identified via incubation with a 
substrate solution which starts an enzyme-substrate reaction: the oxidation of luminol in 
presence of H2O2 and peroxidase enzyme leads to a chemiluminescence reaction in the 
area where labeled antibody is bound. This light reaction was enhanced by a chemical 
enhancer (Western Blot Chemiluminescence Reagent Plus, NEN Life Science Products, 
Cologne, Germany) and imaged by a CCD camera system (Kodak image Station, 
Eastman Kodak Company, Rocester, New York, USA). 
7.5.1 Solutions 
Anodal buffer I, pH 10.4: 
Tris 15 g
Methanol 100 ml
H2O. 400 ml
 
Anodal buffer II, pH 10.4: 
Tris 1.5 g
Methanol 100 ml
H2O 400 ml
 
Cathodal buffer, pH 7.6: 
ε-amino-n-caproic acid 2.6 g
Methanol 100 ml
H2O 400 ml
 
TBS-T pH 8.0 (washing buffer): 
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Tris 3 g
NaCl 11.1 g
Tween 20 1 ml
H2O ad 1000 ml
Adjusting to pH 8.0 
 
7.5.2 Protein transfer by semidry blotting 
Transfer of proteins onto the PVDF membrane was performed by semidry blotting 
between two horizontal graphite electrodes (Fastblot B43, Biometra, Göttingen Germany). 
The discontinuous buffer system leads to an equal and effective protein transfer with 
sharp signals. Additionally, this method is cheap, fast, and simple and requires only a 
small amount of buffer (Kyhse-Andersen, 1984). 
The blotting membrane was cut to the size of the resolving gel and placed for 5 min in 
methanol, H2O and anodal buffer II, respectively. Onto the anode, forming an air bubble 
free stack, 6 sheets of blotting paper (BioRad, Munich, Germany) were placed after 
moistening in anodal buffer I, then, 3 sheets treated with anodal buffer II. Onto this stack 
the membrane and the gel was laid and subsequently covered with 9 sheets of blotting 
paper, moistened with cathodal buffer. 
Blotting was performed at a current of 0.8 mA per cm2 of blotting surface and 115 V. After 
that, the membrane was dried for 30 min at 80°C. 
To mask unspecific binding sites, the membrane was blocked overnight (4°C) in a 5% 
(m/v) solution of low fat milk powder (Blotto, BioRad, Munich, Germany) in TBS-T pH 8.0. 
7.5.3 Used antibodies 
7.5.3.1 HO-1 Western blot 
For HO-1 Western blotting, a monoclonal mouse HO-1 antibody (Stressgen OSA-111, 
Victoria, Canada) served as first antibody, and a polyclonal anti-mouse (Cell signaling 
7072-1, New England Biolabs GmbH, Frankfurt/Main, Germany) as secondary antibody 
conjugated to horseradish peroxidase (HRP) 
7.5.3.2 Caspase-3 
Caspase-3 protein was detected with a polyclonal rabbit antibody (Santa Cruz SC-7148, 
Heidelberg, Germany). Secondary antibody was an anti-rabbit antibody (Dianova, 
Jackson Immuno Research 111-035-144, Hamburg, Germany) coupled to HRP. 
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7.5.4 Incubation with antibodies and chemiluminescence detection 
The antibodies were diluted 1:1000 in a solution of 1% Blotto in TBS-T pH 8.0. After 
incubating the membrane for 60 min with the primary antibody on a shaking platform, 
three washing steps for 10 min in TBS-T pH 8.0 followed. The second antibody was kept 
for 60 min on the blots and again three washing steps were performed. The two detection 
solutions (Western Blot Chemiluminescence Reagent Plus, NEN Life Science Products, 
Cologne, Germany) were mixed 1:1 according to the manufacturer’s instruction and the 
membrane was incubated for 1 min. Chemiluminescence detection was performed on a 
Kodak image station. 
8. In vitro phosphorylation by protein kinase A 
Cyclic AMP dependent protein kinase A (PKA) catalyzes the transfer of γ-phosphate from 
adenosine triphosphate (ATP) to a serine or threonine residue in a protein substrate. This 
phosphorylation activity can be measured by in vitro phosphorylation of a short, 
biotinylated, synthetic and highly specific peptide substrate of defined sequence 
(kemptide: LRRASLG) with radioactively labeled ATP ([γ32P]-ATP) (Pearson et al., 1991). 
The assay was performed with the Protein Kinase A Assay Kit from Calbiochem 
(Schwalbach, Germany) according to the manufacturer’s instructions. 
8.1 Solutions 
Extraction buffer 
Tris-HCl pH 7.4 25 mM
EDTA 0.5 mM
EGTA 0.5 mM
Triton-X 100 0.05% (v/v)
Mercaptoethanol 10 mM
Leupeptin 1 µg/ml
Aprotinin 1 µg/ml
 
Reaction mixture  (volume per sample)
ATP solution 0.15 mM 2.5 µl
Biotinylated kemptide solution 0.25 mM 2.5 µl
Reaction buffer (200 mM MgCl2, 400 mM Tris-HCl pH7.5) 2.5 µl
[γ32P]-ATP (0.2 µCi/µl) 2.5 µl
H2O 10.0 µl
 
Control mixture (volume per sample)
ATP solution 0.15 mM 2.5 µl
Reaction buffer (200 mM MgCl2, 400 mM Tris-HCl pH7.5) 2.5 µl
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[γ32P]-ATP (0.2 µCi/µl) 2.5 µl
H2O 12.5 µl
 
8.2 Preparation of samples 
8.2.1 Liver tissue 
All work was performed in a 4°C cooling chamber. Livers were stored during this time on 
dry ice. 100 mg of liver tissue was added to 500 µl of ice cold lysis buffer and 
homogenized by 10 strokes with a Potter S device (Braun Biotech, Melsungen, Germany). 
Afterwards, homogenates were centrifuged for 20 min at 4°C and 14,000 rpm. Clear 
supernatants were used for the following PKA assay. 
8.2.2 Primary hepatocytes 
Primary hepatocytes were isolated and cultivated as described under 2.4. After 48 h of 
cultivation in 6-well plates, hepatocytes were stimulated with the respective substances 
and harvested after the incubation time by washing 2 times with cold PBS. Cells were 
lysed with 200 µl of extraction buffer per well and homogenized with a hand potter (5 
strokes, Braun Biotech Melsungen, Germany). After centrifugation for 20 min at 4°C and 
14.000 rpm the supernatants were used for the PKA assay. 
8.3 Protein kinase A assay 
Besides the preparation of a reaction mixture with ATP-solution, biotinylated kemptide, 
[γ32P]-ATP, and reaction buffer for measuring phosphorylation of the peptide substrate, a 
control mixture without biotinylated kemptide was set up to determine unspecific 
phosphorylation. Background phosphorylation was determined by preparing a sample with 
reaction mixture but without protein lysate. 
The first step was the incubation of the enzyme sample with the reaction mix containing 
biotinylated peptide substrate and [γ32P]-ATP. This was performed at 37°C for 30 min. The 
reaction was terminated by adding stop solution (8.0 M guanidine hydrochloride). Free 
avidin in solution was supplemented for binding to the biotinylated [γ32P]-peptide product 
and after 5 min of incubation, samples were transferred into centrifuge ultrafiltration units. 
These units contain a membrane that retains the product-avidin complex by affinity 
ultrafiltration but not the free [γ32P]-ATP. After several washing steps the ultrafiltration 
units were directly placed into liquid scintillation vials (Greiner, Frickenhausen, Germany) 
and were counted after addition of 10 ml of scintillation liquid (Rotiszint, Roth, Karlsruhe, 
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Germany) in a multi-purpose scintillation counter (Beckmann LS6500). 
Specific PKA activity was calculated as pmole phosphate incorporated per minute per 
sample amount as described in the instruction manual. 
9. Fluorimetric enzyme activity assay 
Caspases are a family of proteases that act in a cascade triggered by apoptotic signals. 
These enzymes are highly conserved cysteine proteases that specifically and efficiently 
cleave target substrates after the carboxy terminus of aspartate (Nicholson et al., 1997). 
The activation of the downstream caspase-3, considered as one of the major effector 
caspases (Hengartner, 2000), can be measured by applying the synthetic peptide 
substrate DEVD (asp-glu-val-asp). It is coupled to a fluorophor that is cleaved after the 
aspartate residue by the activated enzyme leading to increased fluorescence (Thornberry, 
1994). Because other downstream caspases such as caspase-7 have similar substrate 
specifity, this assay does not exclusively demonstrate caspase-3 activity. Therefore, the 
measured activity is termed “caspase-3-like activity” regarding caspase-3 as the major 
effector caspase. To make detection possible, the DEVD substrate is labeled with a 
fluorescent molecule, 7-amino-4-trifluoromethyl coumarin (AFC). The liberation of this 
fluorophore shows a blue to green shift in fluorescence at an extinction wavelength of 390 
nm and an emission wavelength of 505 nm. AFC as fluorophore is highly sensitive and 
sufficiently stable to handle. 
ONH2 O
FF F
DEVD ON O
FF F
H
DEVD     +caspase cleavage
 
figure 10: liberation of AFC from DEVD-AFC by caspase cleavage (see text). 
The reaction processes linearly at least over 2 h at substrate saturation. Because agents, 
such as air oxygen or traces of metal ions can oxidize the thiol group of the cysteine 
protease and therefore inactivate the enzyme, dithiothreitol (DTT), as a reducing agent, 
was added to the substrate buffer. 
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9.1 Solutions 
Extraction buffer 
HEPES pH 7.5 25 mM
MgCl2 5 mM
EGTA 1 mM
Pefablock SC 1 mM
Pepstatin 1 µg/ml
Leupeptin 1 µg/ml
Aprotinin 1 µg/ml
 
Substrate buffer 
Ac-DEVD-AFC (Biosource, Solingen, Germany) 50 µM
HEPES pH 7.4 50 mM
Sucrose 1% (m/v)
CHAPS 0.1% (m/v)
DTT 10 mM
 
9.2 Caspase-3-like acitivity assay 
Cytosolic extracts from liver tissue were prepared by homogenization in hypotonic 
extraction buffer in a Potter S device (Braun Biotech, Melsungen, Germany). 
Homogenates were subsequently centrifuged (15 min, 14,000 rpm, 4°C), and 
supernatants were stored at -80°C. The fluorometric Ac-DEVD-AFC cleavage assay was 
carried out on microtiter plates (Greiner, Frickenhausen, Germany) according to the 
method originally described by (Nicholson et al., 1995). Cytosolic extracts (10 µl, ~1 mg 
protein/ml) were diluted 1:10 with substrate buffer containing the fluorogenic substrate. 
Blanks contained 10 µl of extraction buffer and 90 µl of substrate buffer. Generation of 
free 7-amino-4-trifluoro-methylcoumarin (AFC) at 37°C was kinetically determined by 
fluorescence measurement (excitation, 385 nm; emission, 505 nm) using a fluorometer 
microplate reader (Fluostar, BMG GmbH, Offenburg, Germany). Enzyme activity was 
calculated using an external AFC (Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany) 
standard curve. The time point where highest enzyme activity was measured was set to 
100%. Protein concentrations of the corresponding samples were estimated with the 
Pierce Assay (see below). Control experiments confirmed that the activity was linear with 
time and with protein concentration under the conditions described above. 
9.3 Protein determination: Pierce-assay (BCA-assay) 
The resulting color of this photometric assay is based on the Biuret reaction of proteins 
with copper in alkali and the interaction of two molecules of bicinchinonic acid (BCA) with 
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one copper (I) ion (Cu+). The purple complex is water soluble and has a strong 
absorbance at 562 nm (Smith et al., 1985). 
Reagent A Na2CO3, NaHCO3, BCA reagent and Na-tartrat in 0.2 mol/L NaOH 
Reagent B 4% aqueous CuSO4-solution
  
50 parts of reagent A were mixed with 1 part of reagent B. 200 µl of this working solution 
were added to 10 µl of sample, incubated at 37°C for 30 min and measured the 
absorbance at 562 nm in a Lambda Bio 20 photometer. By creating standard dilutions with 
bovine serum albumin (0-2000 µg/ml, Sigma-Aldrich Chemie GmbH, Taufkirchen, 
Germany), the corresponding protein concentration was determined. 
10. Histological analysis 
10.1 TUNEL staining 
DNA fragmentation was quantified by the terminal deoxynucleotidyl transferase (TdT) 
mediated dUTP nick end labeling method (TUNEL) (Gavrieli et al., 1992).  
TUNEL staining of paraffin embedded liver sections was performed by Dr. Meißner and 
Andrea Sendelhofert, Institute of Pathology, University of Munich, Germany. 
At indicated time points liver samples were taken and slices were immediately fixed in 
buffered formalin solution (4% formaldehyde). After 48 hours samples were embedded in 
paraffin and cut into 6 µM sections. For evaluation of the number of apoptotic cells liver 
sections were stained with the ApopTag Peroxidase In Situ Apoptosis Detection Kit 
(Intergen, Purchase, New York, USA) as described in detail in the manufacturer’s 
instruction. For quantitation, 10 high power fields were counted (1.96 mm²) using a Zeiss 
Axiolab microscope (Carl Zeiss Mikroskopie, Jena, Germany). This area contained 
approximately 4,000 hepatocytes. The ApopTag staining results were evaluated in 
combination with morphological criteria. All histological evaluations were performed in a 
blinded fashion. 
10.2 Immunohistochemistry 
Immunostaining was performed by Dr. H. Meißner and Andrea Sendelhofert, Institute of 
Pathology, University of Munich, Germany. 
Liver slices were fixed in buffered formalin solution. After 24 h samples were embedded in 
paraffin and cut into 2 µM sections. Paraffin was removed and samples were pretreated 
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by boiling in TRS 6 (Dako Hamburg, Germany) in the microwave. Endogenous peroxidase 
was blocked by treatment with aqueous H2O2 solution. For detection of HO-1, a 
monoclonal antibody from StressGen, Victoria, Canada, was used. The indirect 
peroxidase method was performed with the PicTure–Plus Kit anti mouse (Zymed, San 
Francisco, USA) and red color resulted by use of AEC/Romulin AEC chromogen substrate 
(Biocare medical, Walnut Creek, USA). Blue staining of ED2 (antibody from Serotec, 
Raleigh, USA) as Kupffer cell marker was realized with the ChemMate APAAP Kit 
(Dako, Hamburg, Germany) based on the alkaline phosphatase-anti alkaline phosphatase 
method. As substrate for the alkaline phosphatase served the Alkaline Phosphatase 
Substrate Kit III (Linaris, Wertheim, Germany). Samples were counterstained in 
hematoxylin solution. 
10.3 Hematoxylin/eosin (H/E) staining 
HE staining was performed by Dr. H. Meißner and Andrea Sendelhofert, Institute of 
Pathology, University of Munich, Germany. 
Paraffin embedded liver slices were incubated for 2 min in Papanicolaous solution 1a 
(Harris’ hematoxylin solution), washed for 6 min in demin. water and then incubated for 3 
min in a 0.5% eosin solution. After washing in demin. water (30 sec), the slides were 
immersed in increasing concentrations of ethanol (70%, 96%, 100% ethanol, 5 times 
each) and in xylol solution. The slices were mounted in Eukitt® and photographed (400-
fold amplification, Zeiss Axioskop, Carl Zeiss Mikroskopie, Jena, Germany). 
10.4 Trypan blue uptake of liver tissue 
Experiments were performed by Dr. M. Bilzer (Department of Medicine II) and Dr. H. 
Arnholdt (Institute of Pathology), University of Munich, Germany. 
Trypan blue uptake of necrotic cells was evaluated at the end of the 2-hour reperfusion 
period. Livers were perfused with trypan blue (0.2 mmol/L) for 10 min and fixed with 
formalin (1.5%) during a 5-min perfusion. The fixed liver tissue was embedded in paraffin. 
Slices of liver tissue were stained with eosin to visualize the cytoplasm. 
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11. Statistics 
All data are expressed as mean and standard error, unless stated otherwise. The 
significance of differences between experimental groups was determined by one-way 
ANOVA with Bonferroni post-test or Student’s t-test. p<0.05 was considered statistically 
significant. Analyses were performed with GraphPad Prism, Version 3.02, Graphpad 
Software Inc., San Diego, USA. 
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C. Results 
1. Determination of apoptotic and necrotic cell death 
For discrimination between apoptotic and necrotic cell death, commonly accepted 
biochemical methods combined with morphological criteria were used. As parameters for 
apoptotic cell death caspase-3-like activity in combination with caspase-3 protein 
processing and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate 
nick-end labelling (TUNEL) were performed. Morphological criteria were cell shrinkage, 
chromatin condensation and margination, and the occurrence of apoptotic bodies. 
Necrotic cell death was characterized morphologically after hematoxylin and eosin (HE) 
staining and by determination of trypan blue uptake into injured cells. Cells were counted 
as necrotic when showing increased eosinophilia, vacuolization, cell disruption, loss of 
architecture, and karyolysis. These investigations were performed in a blinded fashion. 
1.1 Evaluation of apoptosis 
1.1.1 ANP and 8-Br-cGMP preconditioning reduce caspase-3-like 
activity and caspase-3 processing 
Fluorometric DEVD-AFC assay showed a maximum of caspase-3-like activity after 24 h of 
cold ischemia. During reperfusion, caspase-3 like activity decreased to the basal activity 
levels of blood-free perfused control livers. Preconditioning with 200 nM ANP significantly 
reduced caspase-3 like activity by 53% after 24 h of cold ischemia and by 52% after 45 
min of reperfusion in comparison to control livers (figure 11). 
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figure 11: ANP preconditioning reduce caspase-3-like activity.  
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Liver were perfused for 30 min, stored in UW solution for 24 h (4°C) and were reperfused for 45 
min and 120 min. At the indicated time points, untreated livers (control) and pre-treated livers 
(ANP 200 nM, 20 min) were snap frozen and prepared for fluorogenic measurement of 
caspase-3-like activity as described under “Materials and Methods”. Columns show mean ± 
SEM of three independent experiments with n=4-5 organs per group. *p<0.05 significantly 
different from untreated control, #p<0.05 significantly different from 0’ (Student’s t-test). 
Similarly, pretreatment of livers with 50 µM 8-Br-cGMP showed a significant reduction of 
caspase-3 like activity after 24 h of cold ischemia. The extent of inhibition after cold 
ischemia was by 51% and after 45 min of reperfusion by 61% (figure 12). Control 
experiments confirmed that ANP and 8-Br-cGMP itself had no direct inhibitory effect on 
caspase-3-like activity (data not shown). 
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figure 12: 8-Br-cGMP preconditioning reduce caspase-3-like activity.  
At indicated time points (0’: shortly perfused, no ischemia; 24 h of cold ischemia; 24 h of cold 
ischemia and 45 min and 120 min of reperfusion, each), control livers and pre-treated livers (8-
Br-cGMP 50 µM) were snap frozen and prepared for fluorogenic measurement of caspase-3-
like activity as described under “Materials and Methods”. Columns show mean ± SEM of three 
independent experiments with n=4-5 organs per group. *p<0.05 significantly different from 
untreated control, #p<0.05 significantly different from 0’ (Student’s t-test). 
Western blot analysis was performed to detect caspase-3 protein cleavage. In pre-
ischemic liver homogenates, caspase-3 precursor CPP32 was clearly detectable in 
contrast to its cleavage product p17, the proteolytic active subunit (figure 13). After 24 h of 
cold ischemia both the amount of precursor and proteolytic active subunit increased to a 
maximum, indicating highest enzyme activity. At 120 min of reperfusion, only small 
amounts of precursor and p17 cleavage product were detectable. 
Preconditioning with ANP diminished the amount of caspase-3 precursor CPP32 and the 
active p17 subunit compared to control livers. This was apparent both after 24 h of cold 
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ischemia and after 120 min of reperfusion (figure 13). 
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figure 13: Reduced processing of caspase-3 in ANP pre-treated livers.  
Liver were perfused for 30 min, stored in UW solution for 24 h (4°C) and were reperfused for 
120 min. At indicated time points, untreated control livers and pre-treated livers (ANP 200 nM) 
were snap frozen. Western blot with caspase-3 antibody was performed as described under 
“Materials and Methods”. CPP32: caspase-3 precursor; p17: proteolytic active subunit. Data 
show one representative blot out of three independent experiments (Western blot: panel A; 
densitometric analysis: panel B: CPP32, panel C: p17). *p<0.01 significantly different from 
untreated control, #p<0.05 significantly different from 0’ (Student’s t-test). Bars show mean ± 
SEM with n=2-3 organs per group. 
Preconditioning with 8-Br-cGMP (figure 14) revealed similar but less distinctive influence 
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on the amount of caspase-3 precursor CPP32. The active p17 subunit was not 
significantly decreased by 8-Br-cGMP compared to control livers. 
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figure 14: Reduced processing of caspase-3 in 8-Br-cGMP pre-treated livers.  
After 30 min of perfusion, livers were stored in UW-solution (4°C) for 24 h and were reperfused 
for 120 min. At indicated time points untreated control livers and pre-treated livers (8-Br-cGMP 
50 µM) were snap frozen. Western blot with caspase-3 antibody was performed as described 
under “Materials and Methods”. CPP32: caspase-3 precursor; p17: proteolytic active subunit. 
Data show a representative blot out of three independent experiments (Western blot: panel A; 
densitometric analysis: panel B: CPP32, panel C: p17). Bars show mean ± SEM with n=2-3 
organs per group. 
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1.1.2 ANP and 8-Br-cGMP preconditioning decrease the proportion of 
TUNEL-positive cells 
Terminal deoxynucleotidyl transferase mediated dUTP nick end labelling (TUNEL) of liver 
sections showed only few TUNEL positive stained hepatocytes and endothelial cells with 
characteristical morphology for apoptosis in control livers at the beginning of perfusion. 
After 24 h of cold ischemia, TUNEL positive hepatocytes increased maximally, decreased 
after 45 min of reperfusion, and again augmented at 120 min. Endothelial cells showed a 
similar pattern for TUNEL positive cells but to a much lesser extent. 
Preconditioning with ANP (figure 15) reduced the number of TUNEL positive hepatocytes 
after 24 h of cold ischemia by 37%, but did not show a significant difference at the 
different reperfusion time points. Staining of endothelial cells was not altered by 
preconditioning with ANP. 
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figure 15: ANP preconditioning decreases proportion of apoptotic cells after ischemia.  
Liver perfusion was performed (30 min), followed by storage in UW-solution for 24 h (4°C), and 
reperfusion for 45 or 120 min At indicated time points, untreated control livers and pre-treated 
livers (ANP 200 nM) were fixed in formalin, imbedded in paraffin, and prepared for TUNEL 
analysis as described under “Materials and Methods”. Columns show mean ± SEM of four to 
five independent experiments. *p<0.05 significantly different from untreated control, #p<0.05 
significantly different from 0’ (Student’s t-test). 
Preconditioning with 8-Br-cGMP (figure 16) similarly to ANP decreased the number of 
TUNEL positive hepatocytes after 24 h of cold ischemia by 28%. Again, there was no 
significant difference during reperfusion and no influence on staining of endothelial cells. 
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figure 16: 8-Br-cGMP preconditioning decreases proportion of apoptotic cells after ischemia. 
At indicated time points (0’: shortly perfused, no ischemia; 24 h of cold ischemia; 24 h of cold 
ischemia and 45 min and 120 min of reperfusion) control livers and pre-treated livers (8-Br-
cGMP 50 µM) were fixed in formalin, embedded in paraffin, and prepared for TUNEL analysis 
as described under “Materials and Methods”. Columns show mean ± SEM of four to five 
independent experiments. *p<0.05 significantly different from untreated control, #p<0.05 
significantly different from 0’ (Student’s t-test). 
1.2 Evaluation of necrosis 
1.2.1 Decreased degenerative changes in ANP pre-treated livers  
HE staining of cold preserved livers displayed significant evidence of cell injury, but only 
few necrotic cells. Hepatocytes showed large, clear vacuoles within the cytoplasm. 
Moderate swelling and loosening of intercellular attachments was visible with predominant 
location in the periportal area. ANP pre-treatment showed decreased degenerative 
changes with less vacuolization and improved cellular integrity (figure 17). 
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figure 17: Degenerative changes of hepatocytes are decreased by ANP pretreatment.  
After 24 h of preservation in UW solution, liver slices were fixed in formalin solution (1.5%) and 
embedded in paraffin. HE staining was performed using a standard protocol. Panel A: Arrows 
show cytoplasmatic vacuolization as indicator of degenerative cell damage in control livers. 
Panel B: ANP pretreated liver slice with improved morphology. Original magnification: 400–fold. 
1.2.2 Trypan blue uptake is significantly reduced by ANP 
preconditioning 
Histological analysis of livers perfused with trypan blue at the end of the 2-hours 
reperfusion period revealed increased staining of liver cells, indicating necrotic cell death. 
Pre-treatment with ANP significantly reduced trypan blue uptake in hepatocytes in 
periportal but not in pericentral areas. Similarly, endothelial cells were protected by ANP 
preconditioning in periportal but not in pericentral areas (figure 18). 
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figure 18: Necrotic damage during reperfusion is reduced by ANP preconditioning in 
hepatocytes.  
After 24 h of preservation in UW solution and 2 h of reperfusion with KH buffer, untreated 
control livers and pretreated livers (ANP 200 nM) were perfused with trypan blue (0.2 mmol/L) 
for 10 minutes and fixed with formalin (1.5%) during a 5-minute perfusion as described under 
“Materials and Methods”. Panel A: quantification of trypan blue uptake in hepatocytes in 
periportal and pericentral areas, panel B: endothelial cells. Columns show mean ± SD of four to 
five independent experiments. *p<0.001 significantly different from untreated control (Student’s 
t-test) 
2. Signal transduction of ANP protection 
2.1 Involvement of cGMP-dependent protein kinases 
Due to controversial information concerning expression of cGMP-dependent protein 
kinases in the liver, the occurrence of cGMP-dependent protein kinases in the liver was 
investigated by RT-PCR. Experiments showed no expression of cGMP-dependent protein 
kinase I (PKG I) in the liver, whereas it could be clearly detected in the brain as positive 
organ (Tamura et al., 1996; Sandberg et al., 1989). Similarly, it was not possible to amplify 
the cGMP-dependent protein kinase II (PKG II). The intestine and the brain, organs with 
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high expression of PKG II (Jarchau et al., 1994), served as positive control(figure 19, 
panel A). Isolation procedure of RNA and reverse transcription were verified by control 
amplification with the house keeping gene GAPDH (figure 19, panel B). These results 
suggested no presence of PKG in livers. 
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figure 19: Expression of cGMP-dependent protein kinases.  
Livers were flushed blood free and prepared as described under “Materials and Methods”. 
Intestine and brain as control organs were immediately removed and rinsed in PBS before snap 
freezing in liquid nitrogen. Panel A: RT-PCR experiments were performed with primers 
detecting cGMP-dependent protein kinase I (PKG I) and II (PKG II). Panel B: Amplification of 
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GAPDH as housekeeping gene was performed with primers detecting GAPDH. Data show one 
out of three independent experiments. 
2.2 Effect of cGMP- and cAMP-dependent protein kinase 
inhibitors on the antiapoptotic property of ANP 
Due to the knowledge of interaction of cGMP with the PKA pathway and to confirm the 
absence of PKG, the involvement of cAMP- and cGMP-dependent protein kinases was 
investigated on their action on apoptotic cell death by the use of specific inhibitors of these 
enzymes.  
Due to their mode of action of binding to the cyclic nucleotide binding sites of the PKG and 
PKA enzymes, the compounds had to be infused into the rat liver before addition of ANP. 
The inhibitors alone had no direct influence on the caspase-3-like activity assay (data not 
shown). 
2.2.1 Effects on caspase-3-like activity 
The influence of the protein kinase inhibitors on apoptotic cell death was investigated after 
24 h of cold ischemia, the time point with highest incidence of apoptosis. Preconditioning 
of livers lead to a significant reduction of caspase-3-like activity and confirmed the results 
shown in 1.1.1. Additional treatment with the cGMP-dependent protein kinase inhibitor Rp-
8-pCPT-cGMPS (1 µM) did not change ANP action. These results suggested no 
involvement of PKG action in hepatoprotection conveyed by ANP supporting the observed 
missing of PKG in the liver. In contrast, infusion of the cAMP-dependent protein kinase 
inhibitor Rp-8-Br-cAMPS (1 µM) completely prevented ANP’s antiapoptotic properties 
pointing to the involvement of PKA (figure 20). Perfusion of inhibitors alone did not 
significantly influence caspase-3-like activity (data not shown). 
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figure 20: Effect of cGMP- and cAMP-dependent protein kinase inhibitors on the antiapoptotic 
property of ANP.  
After 24 h of cold ischemia, control livers and pre-treated livers (ANP 200 nM) were snap frozen 
and prepared for fluorogenic measurement of caspase-3-like activity as described under 
“Materials and Methods”. Rp-8-pCPT-cGMPS (1 µM): PKG inhibitor, Rp-8-Br-cAMPS (1 µM): 
PKA inhibitor. Data are expressed as percent of enzyme activity of untreated control livers at 24 
h of cold ischemia, which was set as 100%. Columns show mean ± SEM of two independent 
experiments with n=4-5 organs per group. *p<0.05 significantly different from untreated control 
and ANP/Rp-8-pCPT-cGMPS treated livers (Student’s t-test). 
2.3 Activation of cAMP-dependent protein kinase by ANP 
The previous results suggested a role for PKA. In order to determine the capability of ANP 
to directly activate cAMP-dependent protein kinase A (PKA) it was investigated whether 
ANP in fact directly activates PKA in whole organs and in isolated hepatocytes. 
2.3.1  Liver 
In whole liver homogenates, 20 min perfusion with ANP lead to a slight increase of PKA 
activity compared to control livers (figure 21). After 24 h of cold ischemia, no difference in 
PKA activity between ANP treated and untreated livers was visible (data not shown). 
These result suggested early effect of ANP on PKA in liver. Due to big variability in the 
values measured the experiments were additionally performed in primary hepatocytes. 
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figure 21: Induction of PKA activity in liver.  
Liver perfusion was performed (30 min) in the presence of ANP (20 min, 200 nM) or absence 
(control). PKA activity assay was performed as described under “Materials and Methods”. 
Values expressed as x-fold increase of specific activity in comparison to untreated control. 
Columns show mean ± SEM of two independent experiments with n=3 organs per group. 
2.3.2 Hepatocytes  
Incubation of hepatocytes with ANP (200 nM) led to a significant increase in PKA activity 
(3.4-fold). Similarly, 8-Br-cGMP activated PKA but to larger extent (5.7-fold). The positive 
control Bt2-cAMP increased PKA activity by 26-fold (figure 22). 
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figure 22: Induction of PKA activity in hepatocytes.  
Hepatocytes were isolated as described under “Materials and Methods”. Cultured hepatocytes 
were left unstimulated (Control) or treated with ANP (200 nM), 8-Br-cGMP (200 µM) and Bt2-
cAMP (250 µM) for 60 min. PKA activity assay was performed as described under “Materials 
and Methods”. Specific activity is expressed as x-fold increase in comparison to untreated 
control. Columns show mean ± SEM of three independent experiments with n=3 samples per 
group. *p<0.05 significantly different from untreated control (Student’s t-test). 
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These results show, that an activation of PKA by ANP or 8-Br-cGMP could contribute to 
the observed antiapoptotic action, that is mitigated by simultaneous perfusion with an PKA 
inhibitor. 
3. Heme oxygenase-1 
Induction of the heme oxygenase-1 enzyme (HO-1) in IRI of the liver is discussed to have 
protective properties. A potential involvement of HO-1 in ANP mediated protection should 
be clarified by determining HO-1 expression in rat livers. 
3.1 cGMP-independent induction of HO-1 by ANP 
preconditioning 
In order to investigate whether HO-1 is upregulated in the system of ischemia and 
reperfusion, HO-1 Western and Northern blots of liver samples obtained pre- and post-
ischemia and at two different time points of reperfusion (45 and 120 min) were performed. 
These experiments revealed no significant changes in HO-1 expression in the course of 
ischemia and reperfusion, neither in HO-1 mRNA nor in protein levels (figure 23). 
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figure 23: HO-1 expression during ischemia and reperfusion.  
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Livers were perfused for 30 min, stored in UW solution for 24 h (4°C), and reperfused for 45 or 
120 min. Panel A: HO-1 mRNA expression was determined by Northern blot. Normalization of 
RNA was performed by probing with a 28S oligonucleotide probe. Values for 0 min (0’: livers 
flushed blood-free with KH buffer) were set as 1. Data show mean ± SEM of phosphorimaging 
values out of two independent blots with n = 2 – 4 organs per treatment group. Panel B: HO-1 
protein expression was determined by Western blots. Experiments were performed as 
described under “Materials and Methods”. 
A significant increase in HO-1 mRNA levels in livers treated with ANP for 20 min was 
observed, whereas ANP did not affect post-ischemic HO-1 mRNA (figure 24). 
A:
B:
0‘            30‘   30‘+ANP
HO-1
28S RNA
0
1
2
3
4
ar
bi
tra
ry
 u
ni
ts
0‘             30‘            24 h isch.          45‘ rep.            120‘ rep.
*
Control
+ ANP
 
figure 24: Influence of ANP preconditioning on HO-1 mRNA expression.  
Panel A shows HO-1 expression of livers preconditioned with ANP (200 nM) for 20 min in 
comparison to untreated organs. Data show one representative out of 6 independent 
experiments. Panel B: Phosphorimaging analysis of Northern blots investigating HO-1 
expression during ischemia and reperfusion. HO-1 signals were normalized by 28S signals 
whereby values for 0 min (0’: livers flushed blood-free with KH buffer) were set as 1. Data show 
mean ± SEM of two independent blots with n = 2 – 4 organs per treatment group *p<0.05 
represents significant differences to untreated organs (Student’s t-test). 
HO-1 protein was slightly but not significantly elevated in ANP-preconditioned livers. ANP 
did not affect post-ischemic protein expression (figure 25). 
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figure 25: Influence of ANP preconditioning on HO-1 protein expression.  
Liver perfusion was performed (30 min) in the presence or absence of ANP (200 nM), followed 
by storage in UW-solution for 24 h (4°C), and reperfusion for 45 or 120 min. HO-1 Western 
blots were performed as described under “Materials and Methods”. Data show one 
representative out of 6 independent experiments. Data show mean ± SEM of two independent 
blots with n = 2 – 4 organs per treatment group. 
In order to elucidate whether the effect of ANP on HO-1 mRNA is mediated via its 
guanylate cyclase coupled A receptor, HO-1 mRNA levels in livers preconditioned with the 
cGMP analogue 8-Br-cGMP (50 µM) were investigated. Interestingly, 8-Br-cGMP did not 
induce HO-1 (figure 26) suggesting that ANP mediates HO-1 induction independently of 
cGMP. 
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figure 26: Influence of 8-Br-cGMP on HO-1 mRNA expression.  
Liver perfusion was performed (30 min) in the presence or absence of 8-Br-cGMP (50 µM), 
followed by storage in UW-solution for 24 h (4°C), and reperfusion for 45 or 120 min. 
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Phosphorimaging analysis of HO-1 Northern blots was performed and signals were normalized 
by 28S signals whereby values for 0 min (0’: livers flushed blood-free with KH buffer) were set 
as 1. Data show mean ± SEM of three independent blots with n = 2 – 4 organs per treatment 
group. *p<0.05 represents significant differences to untreated organs (Student’s t-test). 
3.2 Localization of HO-1 
The next point of interest was to elucidate the cell type responsible for expression of HO-1 
in ANP-treated livers. In situ hybridization experiments showed that HO-1 mRNA in control 
organs is detectable exclusively in Kupffer cells (figure 27). HO-1 mRNA after ANP 
treatment was also only detectable in Kupffer cells.  
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figure 27: Localization of HO-1 mRNA in liver tissue. 
Livers were perfused with KH buffer for 30 min in the absence (control) or presence of ANP 
(200 nM), which was added after 10 min of perfusion. In situ hybridization with antisense and 
sense HO-1 RNA probes was performed in snap-frozen liver samples. Arrows mark cells which 
hybridized the HO-1 probe; due to their immunohistochemical features these cells were 
characterized as Kupffer cells. Original magnification 400–fold as specified in the figure. 
Immunostaining revealed comparable results for HO-1 protein: double-staining with ED2 
and anti-HO-1 antibody indicated that both basal as well as ANP-induced HO-1 protein 
was detectable in Kupffer cells but not in parenchymal cells (figure 28). 
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figure 28: Localization of HO-1 protein in liver tissue.  
Livers were perfused with KH buffer for 30 min in the absence (control) or presence of ANP 
(200 nM), which was added after 10 min of perfusion. Immunohistochemistry: Liver samples 
were immunostained with an anti-ED2 antibody to identify Kupffer cells (blue color). HO-1 
protein expression was visualized by an anti-HO-1 antibody (red color). Costaining was 
performed with both antibodies. Original magnification 400–fold as specified in the figure. 
3.3 Induction of HO-1 in isolated Kupffer cells 
The data obtained with in situ hybridization and with immunostaining indicated that HO-1 
expression induced by ANP occurred only in Kupffer cells but not in parenchymal cells. In 
order to exclude that these data were due to a lack of sensitivity of these techniques for 
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hepatocyte HO-1 expression, additional experiments with isolated liver cells were 
performed. 
Western blot experiments confirmed that ANP in fact induces HO-1 also in purified Kupffer 
cell preparations. Moreover, as shown in whole liver, ANP did not induce HO-1 expression 
in hepatocytes. 8-Br-cGMP was not capable to induce HO-1 in hepatocytes either. The 
positive controls dibutyryl-cAMP and glucagon markedly induced HO-1 in hepatocytes 
which proves that the hepatocytes used were capable to respond to HO-1-inducing stimuli 
(figure 29). 
A:
B:
HO-1
2 h        4 h      6 h     8 h      10 h  12 h   Co
HO-1
Co ANP Bt2-
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HO-1C:
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Glu-
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figure 29: Effects of ANP on HO-1 protein expression in Kupffer cells and hepatocytes.  
Kupffer cells and hepatocytes were isolated as described under “Materials and Methods”. Panel 
A: Isolated Kupffer cells were treated with ANP (200 nM) for the indicated time periods and HO-
1 Western blots were performed. The figure shows one representative out of four independent 
experiments. Panel B: Isolated hepatocytes were treated with ANP (200 nM) for the indicated 
time and HO-1 Western blots were performed. The figure shows one representative blot out of 
4 independent experiments. Panel C: Isolated hepatocytes were treated with ANP (200 nM), 
glucagon (50 nM) or dibutyryl-cAMP (Bt2-cAMP 250 µM) for 6 h and HO-1 Western blots were 
performed. The figure shows one representative out of three independent experiments. 
3.4 ZnPP perfusion 
In order to demonstrate a causal relationship of ANP mediated mitigation of apoptosis and 
induction of HO-1, liver perfusions with the HO-1 activity inhibitor ZnPP were performed. 
Additional perfusion with ZnPP did not abrogate caspase-3-like activity inhibition by ANP. 
Interestingly, ZnPP perfusion by itself lead to a significant reduction of caspase-3-like 
activity. Control experiments revealed no direct interaction of ZnPP with the caspase-3-
like activity assay (data not shown). 
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figure 30: Influence of ZnPP on caspase-3-like activity.  
Liver were perfused for 30 min and stored in UW solution for 24 h (4°C). Untreated control 
livers and pre-treated livers (ANP 200 nM and ZnPP 1 µM) were snap frozen and prepared for 
fluorogenic measurement of caspase-3-like activity as described under “Materials and 
Methods”. Data is expressed as percent of enzyme activity of untreated control livers at 24 h of 
cold ischemia, which was set to 100%. Columns show mean ± SEM of two independent 
experiments with n=3-5 organs per group. *p<0.001 vs. untreated control (Student’s t-test). 
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D. Discussion 
The cardiovascular hormone ANP has previously been demonstrated to protect livers 
against ischemia-reperfusion injury (Gerbes et al., 1998). Aim of this work was the further 
characterization of protection and the elucidation of the associated signal transduction 
mechanisms. 
1. Reduction of apoptosis and necrosis by ANP 
Necrotic and apoptotic cell death was evaluated by applying common biochemical 
techniques (Miyoshi et al., 1999). Caspase-3-like enzyme activation is known as an 
important characteristic of apoptotic cell death (Hengartner, 2000). Additionally to the 
results generated by measuring caspase-3-like activity, TUNEL analysis was performed to 
verify the occurrence of apoptotic cell death (Gavrieli et al., 1992). The TUNEL assay 
detects DNA strand breaks by enzymatically labeling the free 3’-OH termini with modified 
nucleotides. These new DNA ends are generated upon DNA fragmentation and are 
typically localized in morphologically identifiable nuclei and apoptotic bodies. In contrast, 
normal or proliferative nuclei, which have relatively insignificant numbers of DNA 3’-OH 
ends, are usually not stained. In some cases, cells exhibiting necrotic morphology may be 
stained (Grasl-Kraupp et al., 1995). For this reason staining results were evaluated in 
conjunction with morphological criteria. Commonly accepted parameters of apoptosis, 
such as cell shrinkage, chromatin condensation and margination, and the occurrence of 
apoptotic bodies were therefore taken into account (Gujral et al., 2001; Miyoshi et al., 
1999). 
1.1 Reduction of apoptosis by ANP treatment 
Apoptotic cell death was highest after 24 h of cold ischemia. This demonstrates an 
activation of the apoptotic cascade already during the ischemic period supporting the 
observations of Soeda et al. (Soeda et al., 2001) and Rentsch et al. (Rentsch et al., 2001). 
TUNEL analysis revealed that mainly hepatocytes were affected, whereas SEC showed 
only minor damage. This finding is in contrast to other groups, who regard SEC as the 
main target of reperfusion injury (Natori et al., 1999), but similar results were shown by 
Rentsch et al. (Rentsch et al., 2001). 
Preconditioning with ANP led to a significant reduction of apoptosis after 24 h of cold 
ischemia and 45 min of reperfusion, respectively. Protection affected predominantly 
hepatocytes, whereas apoptosis of SEC was not influenced by ANP. Interestingly, 
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preconditioning of livers with 8-Br-cGMP resulted in a similar reduction of apoptosis. This 
analog of ANP’s second messenger cGMP has previously been shown to mimic ANP 
action on liver protection, suggesting a cGMP mediated mechanism (Gerbes et al., 1998). 
Preconditioning with either compound reduced apoptotic cell death after 24 h of ischemia 
by half, but this kind of cell death only comprised about 0.8% of total cells evaluated by 
TUNEL analysis. This points to a minor relevance of apoptosis in the model of IRI in the 
isolated perfused rat liver, which is supported in an in vivo model by Redaelli et al. 
(Redaelli et al., 2002) but is in contrast to the findings of others (Gao et al., 1998).  
The finding that ANP reduces apoptotic together with necrotic cell death in the liver, 
represents a novel aspect of ANP action. ANP has been reported to induce apoptosis in 
cardiac myocytes of rats (Filippatos et al., 2001), whereas ANP protected rat PC12 cells 
from apoptosis (Fiscus et al., 2001). This suggests a highly cell-type specific regulation of 
apoptotic processes exerted by ANP with unclear mechanisms. 
1.2 Caspase-3 upregulation during cold ischemia 
Interestingly, Western blot analysis revealed a significant increase of caspase-3 precursor 
CPP32 during the ischemic period. Similarly, a transcriptional (Harrison et al., 2001) and 
translational (Krupinski et al., 2000) caspase-3 induction was demonstrated in a model of 
permanent middle cerebral artery occlusion, although at a temperature of 37°C. Indeed, 
the induction of transcriptional processes in cold ischemia has been shown for other 
genes before: despite substrate depletion and reduced metabolism endothelin-1 is 
upregulated in the preserved kidney (Wilhelm et al., 1999). In addition, there is clear 
evidence for metabolic activity in cold ischemia as demonstrated by stimulation of stress-
activated protein kinases by Crenesse et al. (Crenesse et al., 2000). 
Surprisingly, the amount of caspase-3 precursor CPP32 declined in the reperfusion 
period. This could be explained, at least partly, by the non-recirculating perfusion system 
leading to removal of apoptotic and wash out of necrotic cells. 
1.3 ANP reduces early degenerative cell changes 
HE staining of livers which had undergone ischemia without reperfusion did not identify 
necrotic cells, but revealed loss of cell integrity and increased vacuolization. These 
reversible, predominantly periportal changes are suggested to develop necrotic cell death 
in the reperfusion period. ANP revealed its protective potential already after 24 h of cold 
ischemia by clearly improving morphological appearance. 
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1.4 Reduction of necrosis by ANP treatment 
Necrotic cell damage was clearly manifest after 2 h of reperfusion. Trypan blue is 
selectively taken up by injured cells and regarded as an indicator of necrotic cell death. In 
trypan blue perfused livers after 2 h of reperfusion, both periportal and pericentral regions 
showed necrotic changes in hepatocytes and SEC. 
Similarly to apoptotic cell damage, preconditioning with ANP led to reduced necrotic 
damage after 2 h of reperfusion. Hepatocytes and SEC were protected in periportal areas 
whereas pericentral areas were not influenced.  
Recently, Kiemer et al. reported that ANP stimulates phagocytic activity of Kupffer cells 
(Kiemer et al., 2002a). Reduced phagocytosis by Kupffer cells is proposed to lead to 
accumulation of toxic metabolites released by dying cells and further aggravation of injury 
(Wanner et al., 1999). By increasing Kupffer cell clearance capacity ANP might ameliorate 
liver injury by removing damaged cells.  
ANP was moreover shown to prevent from Kupffer cell induced oxidant stress (Bilzer et 
al., 1999a) as it similarly occurs during reperfusion. Due to the predominant localization of 
Kupffer cells in periportal liver areas (Gerok et al., 1995), modulation of Kupffer cell 
function might account for the observed mitigation of periportal cell damage. 
In summary, the results of this part of the study provide the following novel findings: 1. 
ANP is able to diminish apoptotic cell damage. 2. Cold ischemia induces procaspase-3. 3. 
ANP reduces ischemic degenerative cell changes. 4. Necrotic cell damage during 
reperfusion is decreased periportally by ANP. 
2. Signal transduction of ANP protection 
2.1 cGMP-dependent protein kinases 
Information about the signal transduction related to the protective action conferred by ANP 
is still scanty. The intracellular formation of cGMP after ANP binding to its receptor was 
suggested to contribute to protection (Gerbes et al., 1998). This also seems to be the 
predominant signaling pathway for ANP’s renal and hemodynamic effects. But the 
mechanisms beyond cGMP, however are as yet unclear. 
The cGMP-dependent protein kinases (PKGs) as target proteins of cGMP (Vaandrager et 
al., 1996) were suggested to be involved in the observed effects. ANP’s second 
messenger cGMP stimulates PKGs, which are able to reduce cytosolic Ca2+ concentration 
Discussion  81 
(Lincoln et al., 1993) leading to vasorelaxation and positively influencing intracellular ion 
homeostasis. It was proposed that the Ca2+ reducing properties of ANP via PKG could 
contribute to the protection (Pella, 1991; von Ruecker et al., 1989). The prerequisite for a 
protection by this mechanisms is the expression of PKGs in the liver. 
The presence of PKGs in the liver was demonstrated by Ecker et al. (Ecker et al., 1989) 
by immunohistochemistry. Because of the fact that platelets contain large amounts of 
PKG protein (Waldmann et al., 1986), it has to be noted that positive 
immunohistochemistry can also result from remaining platelets or other PKG containing 
blood constituents. In contrast, other groups reported low to no expression of PKG mRNA 
in the liver, making the presence and significance of these kinases in the liver still 
questionable (Jarchau et al., 1994; Tamura et al., 1996; Sandberg et al., 1989). In 
addition, in preparations of rat liver endoplasmatic retikulum no PKG activity was evident 
(Kosmopoulou et al., 1994), further suggesting the absence of PKG in the liver. 
This study can not verify the expression of both major isoforms of the PKGs in the rat 
liver. RT-PCR experiments revealed no amplification in the liver, whereas control organs 
showed the expected amplicons. Based on these results, the involvement of PKGs in ANP 
mediated protection seems unlikely.  
A functional relationship between ANP protection and PKG activation function could also 
be excluded since perfusion of ANP treated rat livers with a specific inhibitor of PKG, Rp-
8-pCPT-cGMPS, did not abrogate hepatoprotection, further supporting the missing of a 
functional role of PKG. This inhibitor shows high lipophilicity, but is still water soluble and 
phosphodiesterase stable. It is a competitive inhibitor for both PKG I and PKG II, and is 
sufficiently selective for PKG over PKA (Schwede et al., 2000).  
2.2 cAMP-dependent protein kinases 
Under some conditions also PKA can act as a target molecule for cGMP (Cornwell et al., 
1994). For example, testosterone production by ANP results in isolated mouse Leydig 
cells from an activation of PKA by cGMP (Schumacher et al., 1992). 
In order to demonstrate the existence of this pathway in our system, livers were perfused 
with ANP and a cAMP-dependent protein kinase (PKA) inhibitor, Rp-8-Br-cAMPS. 
Treatment with both compounds was able to abrogate the antiapoptic properties pointing 
to a PKA mediated mechanism. The inhibitor used has similar chemical properties as the 
PKG inhibitor but shows preference in inhibiting the PKA I to the PKA II isoform. 
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The activation of PKA has been shown to be antiapoptotic in numerous studies. For 
example, PKA expression is increased in a wide range of cancers (Alper et al., 1999) and 
antisense RNA of PKA produces a marked decrease in proliferation in cancer cell lines. 
Activation of PKA leads to inhibition of apoptosis in a number of cell types, including 
neutrophils (Parvathenani et al., 1998; Rossi et al., 1995), smooth muscles (Orlov et al., 
1999), and HL60 promyeloid leukemia cells (Jun et al., 1998). Interestingly, the 
antiapoptotic effects are independent of the apoptotic stimuli used. The inhibitory action of 
PKA lies upstream of caspase-3 activation (Parvathenani et al., 1998; Orlov et al., 1999), 
and it is suggested that PKA phosphorylates and therefore inactivates the proapoptotic 
protein Bad at ser112 (Harada et al., 1999). Importantly, all studies suggesting an 
antiapoptotic role focused on the PKA I isoform, which is preferentially inhibited by the 
inhibitor used in the present experiments. 
Moreover, antiapoptotic action of PKA in the liver was demonstrated by Akbar et al. in cold 
stored liver grafts. Supplementation of the organ preservation solution with dibutyryl-cAMP 
mitigated apoptotic cell death after cold storage and led to increased phosphorylation of 
Bad at ser112 (Akbar et al., 2001). Postischemic enzyme leakage of alanine 
aminotransferase was reduced whereas hepatic bile production was enhanced. 
This was further supported by Li et al. who reported that cGMP- and cAMP analogs 
reduce TNF-α/Act-D mediated apoptosis in primary hepatocytes (Li et al., 2000). The 
inhibition of caspase activation and cytochrome-c release was attributed to both PKA-
dependent and -independent mechanisms. 
Furthermore, our results from in vitro stimulation of hepatocytes by ANP underscore this 
hypothesis. Thereby, ANP and 8-Br-cGMP were both able to increase PKA activity. 
In summary, this part of the study demonstrates that cGMP-dependent protein kinases 
seem to be absent in the rat liver and therefore do not contribute to ANP mediated 
protection. Rather, a participation of cAMP-dependent protein kinases is discussed to be 
responsible for the beneficial effects of ANP. 
2.3 Further potentially involved pathways 
There are further approaches to explain the ANP action: activation of the MAPK pathways 
is discussed to contribute to cytoprotection in IRI (Fung, 2001). Induction of p38 MAPK in 
hepatocytes has been demonstrated to attenuate apoptotic cell death (Roberts et al., 
2000; Amersi et al., 2002). In this context it is interesting to know that we were able to 
demonstrate a strong increase of p38 MAPK activity by preconditioning of rat livers with 
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ANP (unpublished data). 
ANP has recently been shown to activate the heat shock transcription factor (HSF) and 
the heat shock protein 70 (HSP70) (Kiemer et al., 2002b), both mediators of the heat 
shock response (Jäättelä, 1999). The antiapoptotic properties of HSP70 might contribute 
to the observed ANP effects (Beere, 2001; Ikeyama et al., 2001). 
3. Heme Oxygenase-1 expression 
Induction of heme oxygenase-1 is discussed to mediate cytoprotection in IRI (Amersi et 
al., 1999). Therefore, the expression of HO-1 in ANP pretreated livers was investigated in 
order to elucidate a potential induction by ANP. 
3.1 HO-1 expression during ischemia and reperfusion 
The presented data show no change in the expression of HO-1 during ischemia and 
reperfusion in the system of cold ischemic storage and reperfusion of isolated rat livers. In 
contrast to this observation, induction of HO-1 during reperfusion has been reported 
(Yamaguchi et al., 1996; Sonin et al., 1999). These investigations, however, were 
performed after warm ischemia with reperfusion times as long as 4 or 6 h (Sonin et al., 
1999). Therefore, the shorter time scale of the experimental setting might be responsible 
for the lack of increased HO-1 expression. 
Moreover, cold ischemia might induce other mechanisms than warm ischemic storage. 
There is little information on HO-1 after cold ischemic liver storage as yet. One work was 
performed in fatty rat livers which underwent cold ischemic storage. It showed no 
alteration in HO-1 expression compared to untreated control organs during up to 2 h of 
reperfusion (Amersi et al., 1999) and therefore supports our data. 
3.2 ANP induces HO-1 in rat livers 
The observation that ANP induces HO-1 is in line with published work showing HO-1 
induction by ANP in cultured bovine aortic endothelial cells (Polte et al., 2000) and renal 
cells (Polte et al., 2002). However, to our knowledge, there are no investigations 
concerning effects of ANP on HO-1 in liver so far. 
It was recently shown by Kiemer et al. (Kiemer et al., 2002b) that ANP represents a 
pharmacological inducer of the heat shock response in rat livers including the activation of 
the heat shock transcription factor (HSF) (Jäättelä, 1999). Due to the characteristic of HO-
1 as a heat shock protein involving a HSF-binding heat shock element in its promotor 
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region, transcriptional induction by ANP might be mediated via this pathway (Maines, 
1997; Shibahara et al., 1989). 
It might seem amazing that HO-1 is upregulated as early as 20 min after ANP treatment. 
Very early cardiac induction of HO-1 mRNA after only 6 min of administration of an NO 
donor has also been described in the literature (Katori et al., 2000). Assuming that 
upregulation of HO-1 is mediated by activated HSF, this rapid elevation is understandable 
since an increase in the binding of HSF to the promotor region of the gene involves 
message stabilization as a major factor in accumulation of the transcript (Maines, 1997; 
Raju et al., 1994). 
3.3 Induction of HO-1 in Kupffer cells 
Interestingly, ANP induces the expression of HO-1 in Kupffer cells but not in parenchymal 
cells. Most data from the literature report parenchymal induction of HO-1 (Paxian et al., 
2001; Terajima et al., 2000; Rizzardini et al., 1998). After hemorrhagic shock (Hoetzel et 
al., 2001; Paxian et al., 2001) and hyperthermia (Terajima et al., 2000) in rats and after 
LPS treatment of mice (Rizzardini et al., 1998), HO-1 was reported to be induced 
predominantly in hepatocytes. However, localization of HO-1 induction in the liver seems 
to be dependent on the type of stimulus. In human cirrhosis HO-1 induction mostly 
occurred in Kupffer cells and was minor in hepatocytes (Makino et al., 2001). Bauer et al. 
reported rat HO-1 induction in sinusoidal lining cells after LPS challenge (Bauer et al., 
1998). These data suggest that specific stimuli induce signaling cascades leading to a 
cell-type specific regulation of HO-1. 
Compared to other papers reporting induction of HO-1 in hepatocytes (Paxian et al., 2001; 
Terajima et al., 2000; Rizzardini et al., 1998), our data show a rather weak yet significant 
induction of HO-1. The lack of induction of HO-1 in hepatocytes might explain the 
moderate increase in HO-1 in our system. 
3.4 Induction of HO-1 by ANP is independent of cGMP 
It has been reported before that ANP induces HO-1 in cultured bovine endothelial cells 
(Polte et al., 2000). In this cell system, however, ANP worked via its guanylate-cyclase-
coupled A receptor. In contrast to these data our findings reveal that ANP-mediated 
induction of HO-1 is exerted independent of cGMP. 
In this context it should be noted that some effects of ANP seem to be independent of 
cGMP, such as attenuation of proliferation in astroglial cells (Levin et al., 1991), reduction 
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of endothelin expression in endothelial cells (Hu et al., 1992), or inhibition of COX-2 
expression in macrophages (Kiemer et al., 2002c). The ANP “clearance” receptor was 
suggested to be responsible for these effects (Levin et al., 1991; Hu et al., 1992; Kiemer 
et al., 2002c). This receptor has been shown to be expressed in liver tissue (Vollmar et al., 
1997). 
This result showing ANP-mediated HO-1 expression is the first report to describe cGMP-
independent action of ANP in the liver, suggesting a pleiotropic biological profile of ANP in 
liver tissue. 
3.5 Perfusion with ZnPP 
Zinc protoporphyrin (ZnPP) inhibits the catalytic activity of both HO-1 and –2. Several 
groups have demonstrated with this compound a causal relationship between HO-1 
induction and cytoprotection (Amersi et al., 1999). 
In this study, ZnPP was not able to abrogate the ANP mediated inhibition of caspase-3-
like activity, suggesting that ANP’s hepatoprotective action is not mediated via the HO-1 
pathway. Surprisingly, this compound itself lead to a significant reduction of caspase 
activity, implying the existence of side effects conferred by this compound. 
In summary, it is demonstrated that preconditioning of rat livers with Atrial Natriuretic 
Peptide induces early HO-1 expression. Interestingly, this induction occurs independently 
of cGMP and localization was confined to Kupffer cells but was not detectable in 
hepatocytes. Induction of HO-1 does not seem to mediate the antiapoptotic action of ANP. 
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E. Summary 
This work characterizes the protective effects of ANP preconditioning in ischemia-
reperfusion injury of the isolated perfused rat liver. It was of particular interest to evaluate  
the influence of ANP on the mode of cell death occurring during cold ischemia and 
reperfusion and to elucidate the involved signal transduction pathways. 
Apoptotic cell death was mainly seen after cold liver storage, whereas necrosis was 
predominant in the reperfusion period. 
It could be demonstrated for the first time that preconditioning with ANP was able to 
reduce both apoptotic as well as necrotic cell death. After cold ischemia, in particular 
hepatocytes were protected against apoptosis. After reperfusion, protection against 
necrosis comprised hepatocytes and sinusendothelial cells predominantly in the periportal 
liver areas. 
As target molecules for ANP action, the cGMP-dependent protein kinases did not seem to 
be responsible for the conferred cytoprotection. In the liver, no expression of these 
kinases could be detected and a functional connection could not be derived. In contrast, 
the cAMP-dependent protein kinases were identified to promote survival. This was further 
supported by the ability of ANP to directly activate cAMP-dependent protein kinases in 
livers and hepatocytes. 
An early transcriptional induction of HO-1 by ANP independent of cGMP could be 
demonstrated. The induction of heme oxygenase-1 by ANP might not be responsible for 
the observed hepatoprotection, since inhibition of HO-1 activity did not abrogate the ANP 
effect. Interestingly, cell-type specific evaluation detected that induction of HO-1 in livers 
by ANP is exclusively restricted to Kupffer cells. 
In summary, this thesis gives new insights into the actions of the cardiovascular hormone 
ANP in IRI of the rat liver. This data helps to understand the mechanisms of how ANP 
mediates cytoprotection by illuminating effects and potential pathways, an important 
prerequisite for a rational application in therapy. 
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F. Appendix 
1. Abbreviations 
A Ampère 
ANP Atrial natriuretic peptide 
APS Ammonium persulfate 
ATP Adenosine-5’-triphosphate 
BNP Brain natriuretic peptide 
Bp Basepair 
Bq Bequerel 
BSA Bovine serum albumine 
cAMP Cyclic Adenosine-5’-monophosphate 
cDNA Complementary DNA 
cGMP Cyclic Guanosine-5’-monophophate 
Ci Curie (1 Ci=3.7x107 Bequerel) 
CNP C-type natriuretic peptide 
Co Control 
cpm Counts per minute 
Da Dalton 
dATP 2’-deoxyadenosine-5’-triphosphate 
dCTP 2’-deoxycytosine-5’-triphosphate 
dGTP 2’-deoxyguanosine-5’-triphosphate 
DMSO Dimethylsulfoxide 
DNA Deoxyribonucleic acid 
dNTP Desoxynucleosidtriphosphate 
DTT Dithiothreitol 
dUTP 2'-deoxyuridine 5'-triphosphate 
EDTA Ethylenediaminetetraacetic acid 
EGTA Ethyleneglycol-bis(aminoethylether)-tetraacetic acid 
EtBr Ethidium bromide 
EtOH Ethanol 
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FCS Fetal calf serum 
GDP Glyoxal DMSO phosphate 
GTP Guanosine-5’-triphosphate 
h Hour 
HRP Horseradish peroxidase 
IRI Ischemia reperfusion injury 
kDA Kilo Dalton 
L Liter 
LDH Lactate dehydrogenase 
m Milli 
M Molar 
MeOH Methanol 
min Minute 
MOPS 3-[N-Morpholino]propansulfonic acid 
MRNA Messenger ribonucleic acid 
n Nano 
NADH Nicotinamide adenine dinucleotid 
NPR Natriuretic peptide receotor 
NTP ATP, CTP, GTP or TTP 
OD Optical density 
PAA Polyacrylamide 
PAGE Polyacrylamide-gel electrophoresis 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PKA cAMP-dependent protein kinase 
PKG cGMP-dependent protein kinase 
PMSF Phenylmethylsulfonylfluoride 
RNA Ribonucleic acid 
RNase Ribonuclease 
Rp-8-Br-cAMPS 8-Bromoadenosine-3',5'-cyclic 
monophosphorothioate, Rp-isomer 
Rp-8-pCPT-cGMPS  8-(4-Chlorophenylthio)guanosine-3',5'-cyclic 
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monophosphorothioate, Rp-isomer 
rpm Rotations per minute 
RT Room temperature 
SA-PMP Strepavidin paramagnetic particles 
SDS Sodium dodecyl sulfate 
sec Second 
SEM Standard error of mean 
SSC Saline sodium citrate buffer 
STE Sodium chloride, Tris, EDTA buffer 
TAE Tris, acetate, EDTA buffer 
TBE Tris, borate, EDTA buffer 
TBS-T Phosphate buffered saline solution with Tween 
TE Tris-EDTA buffer 
TEMED Tetramethylethylenediamine 
TNF-α Tumor necrosis factor alpha 
totRNA Total RNA 
Tris Tris-hydroxymethyl-aminomethan 
TUNEL Terminal deoxynuceotidyl transferase mediated 
dUTP nick end labeling 
U Unit 
UTP Uridine-5’-triphosphate 
V Volt 
W Watt 
ZnPP Zinc protoporphyrin IX 
% (m/v) Mass per volume per cent 
% (v/v) Volume per cent 
µ Micro 
8-Br-cGMP 8-Bromoguanosine-3', 5'-cyclic monophosphate 
 
 
 
90 Alphabetical order of companies 
2. Alphabetical order of companies 
Alexis Biochemicals Grünberg, Germany 
Amersham Braunschweig, Germany 
Beckmann Instruments Munich, Germany 
Biolog Hamburg, Germany 
Biometra Göttingen, Germany 
BioRad Laboratories Munich, Germany 
Biosource Nivelle, Belgium 
Biozym Diagnostics Oldendorf, Germany 
BMG GmbH Offenburg, Germany 
Boehringer Mannheim, Germany 
Braun Melsungen, Germany 
Calbiochem Schwalbach, Germany 
Cell Signaling Frankfurt/Main, Germany 
Charles-River GmbH Sulzfeld, Germany 
Dianova Hamburg, Germany 
DuPont Bad Homburg, Germany 
Eastmen Kodak Company Rocester, USA 
Eppendorf Maintal, Germany 
Gibco/Invitrogen Karlsruhe, Germany 
Greiner Frickenhausen, Germany 
Hamilton Bonaduz, Switzerland 
Heraeus Hanau, Germany 
Ika Labortechnik Staufen, Germany 
Intergen Purchase, USA 
Labsysteme Osvath Geretsried, Germany 
Linde Unterschleißheim, Germany 
MBI Fermentas St. Leon Roth, Germany 
Merck-Eurolab Munich, Germany 
Merial Halbergmoos, Germany 
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Millipore Eschborn, Germany 
MWG-biotech Ebersberg, Germany 
NEN Cologne, Germany 
Owl separation systems Portsmouth, USA 
PAN Aidenbach, Germany 
PE applied biosystems Foster City, USA 
Perkin-Elmer Rodgau-Jügesheim, Germany 
Peske Aindling-Pichl, Germany 
Pharmacia Biotech Heidelberg, Germany 
Pierce Rockford, USA 
Promega Heidelberg, Germany 
Prominent Heidelberg, Germany 
Qiagen Hilden, Germany 
Raytest Straubenhardt, Germany 
Roche Diagnostics Mannheim, Germany 
Roth Karlsruhe, Germany 
Santa Cruz Heidelberg, Germany 
Schleicher & Schüll Dassel, Germany 
Serva Heidelberg, Germany 
Sigma Taufkirchen, Germany 
Sims Portex Ltd. Hyte, UK 
Ssniff Soest, Germany 
Stratagene Heidelberg, Germany 
Stressgen San Diego, USA 
Toplab Martinsried, Germany 
Uniequip Martinsried, Germany 
Watson Marlow Falmouth, UK 
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